| 1 | date | 7,450 |
| 2 | dates | 396 |
| 3 | friday | 75 |
| 4 | extubate | 28 |
| 5 | 17-year-olds | 17 |
| 6 | belch | 17 |
| 7 | bleeding/pain | 11 |
| 8 | confess | 9 |
| 9 | 14t | 8 |
| 10 | betalactams | 8 |
| 11 | iasi | 8 |
| 12 | 60days | 7 |
| 13 | fruition | 7 |
| 14 | landlines | 7 |
| 15 | 24:5n-3 | 6 |
| 16 | lt-i | 6 |
| 17 | midtest | 6 |
| 18 | ad/dementia | 5 |
| 19 | bu+clo+flu+sor | 5 |
| 20 | defervesce | 5 |
| 21 | euthanization | 5 |
| 22 | marañón | 5 |
| 23 | pretensioning | 5 |
| 24 | procreate | 5 |
| 25 | self-protect | 5 |
| 26 | triple-threaded | 5 |
| 27 | vsa-pam | 5 |
| 28 | 19-year-olds | 4 |
| 29 | 2.2±0.7 | 4 |
| 30 | 29±1 | 4 |
| 31 | 44-year-olds | 4 |
| 32 | 50min | 4 |
| 33 | 600μm | 4 |
| 34 | amino-penicillins | 4 |
| 35 | bpda | 4 |
| 36 | cs-tdcs | 4 |
| 37 | erucin | 4 |
| 38 | ethephon | 4 |
| 39 | fluoxetine-only | 4 |
| 40 | fty-bl | 4 |
| 41 | mists | 4 |
| 42 | ohv | 4 |
| 43 | pharmaco-economics | 4 |
| 44 | s-lps | 4 |
| 45 | traditional-only | 4 |
| 46 | vinylsulfidoboron | 4 |
| 47 | 0.35°c | 3 |
| 48 | 07/2001 | 3 |
| 49 | 1.17+/-0.23 | 3 |
| 50 | 1000ng/ml | 3 |
| 51 | 40g/day | 3 |
| 52 | 54-year-olds | 3 |
| 53 | 64-year-olds | 3 |
| 54 | 69-year-olds | 3 |
| 55 | ap24567 | 3 |
| 56 | bu+clo+flu | 3 |
| 57 | cav3-wt | 3 |
| 58 | cis-3-hexene | 3 |
| 59 | ckd-4 | 3 |
| 60 | eight-hours | 3 |
| 61 | end-r | 3 |
| 62 | endoxylanases | 3 |
| 63 | eotp | 3 |
| 64 | gsg | 3 |
| 65 | haems | 3 |
| 66 | hiv-serostatus | 3 |
| 67 | injury/reperfusion | 3 |
| 68 | mace+ | 3 |
| 69 | medicus/medline | 3 |
| 70 | ratrav | 3 |
| 71 | re-dose | 3 |
| 72 | re-epithelialize | 3 |
| 73 | shoals | 3 |
| 74 | shoplift | 3 |
| 75 | slt5 | 3 |
| 76 | tcu-pa | 3 |
| 77 | test-temperatures | 3 |
| 78 | thiolates | 3 |
| 79 | treat=9 | 3 |
| 80 | underprescription | 3 |
| 81 | unmed | 3 |
| 82 | ≤5° | 3 |
| 83 | -0.138 | 2 |
| 84 | -0.141 | 2 |
| 85 | -10.38 | 2 |
| 86 | -10.94 | 2 |
| 87 | -1·51 | 2 |
| 88 | -32.22 | 2 |
| 89 | -adrenoblockers | 2 |
| 90 | 0.20-1.00 | 2 |
| 91 | 0.7653 | 2 |
| 92 | 03/31/2011 | 2 |
| 93 | 08/2012 | 2 |
| 94 | 1-cyano-1,3-butadiene | 2 |
| 95 | 1-dodecanol | 2 |
| 96 | 1.538 | 2 |
| 97 | 1.684 | 2 |
| 98 | 1/800 | 2 |
| 99 | 11:00am | 2 |
| 100 | 13years | 2 |
| 101 | 15,000/mm3 | 2 |
| 102 | 15-y-old | 2 |
| 103 | 239.68 | 2 |
| 104 | 24.38 | 2 |
| 105 | 3-pyridylnitrenes | 2 |
| 106 | 3tc/ftc | 2 |
| 107 | 4-hydroxy-2-ketobutyrate | 2 |
| 108 | 41.75 | 2 |
| 109 | 43.0°c | 2 |
| 110 | 59-year-olds | 2 |
| 111 | 83.17 | 2 |
| 112 | accurate-reporting | 2 |
| 113 | adiabaticity | 2 |
| 114 | angiomyxomas | 2 |
| 115 | anoxia-reoxygenation | 2 |
| 116 | antibiotics/chemotherapeutics | 2 |
| 117 | arabinosylthymine | 2 |
| 118 | avgtmean | 2 |
| 119 | bde-154 | 2 |
| 120 | bias.meta-analyses | 2 |
| 121 | bilharzias | 2 |
| 122 | biopersistence | 2 |
| 123 | brining | 2 |
| 124 | cefoxitine | 2 |
| 125 | cephotaxim | 2 |
| 126 | ch2fcd2cl | 2 |
| 127 | clidox-s | 2 |
| 128 | cntln | 2 |
| 129 | commonness | 2 |
| 130 | condensed-phase | 2 |
| 131 | counsellee | 2 |
| 132 | dauricum | 2 |
| 133 | decannulate | 2 |
| 134 | declassified | 2 |
| 135 | dihydroergotamine/metoclopramide | 2 |
| 136 | diverticuli | 2 |
| 137 | episclera | 2 |
| 138 | exercise+hsgs | 2 |
| 139 | falsifications | 2 |
| 140 | fimbriectomy | 2 |
| 141 | fourtheme | 2 |
| 142 | gal-8 | 2 |
| 143 | glit | 2 |
| 144 | grayanotoxins | 2 |
| 145 | hbv-genotypes | 2 |
| 146 | hodja | 2 |
| 147 | hpv-6/11 | 2 |
| 148 | immuno-incompetence | 2 |
| 149 | indisulam | 2 |
| 150 | introspect | 2 |
| 151 | just/us | 2 |
| 152 | lhex | 2 |
| 153 | lp1-ibdv | 2 |
| 154 | mean≥3.00 | 2 |
| 155 | methylxantines | 2 |
| 156 | mfs/cess | 2 |
| 157 | microatheromas | 2 |
| 158 | mtz-plac | 2 |
| 159 | non-doctors | 2 |
| 160 | non-employment | 2 |
| 161 | nursing-homes | 2 |
| 162 | olinda|exm | 2 |
| 163 | over-harvesting | 2 |
| 164 | passover | 2 |
| 165 | phosphatidylinositol-3,4,5-triphosphate | 2 |
| 166 | phospho-s1444 | 2 |
| 167 | pn7 | 2 |
| 168 | radiosterilization | 2 |
| 169 | rbc-c-a | 2 |
| 170 | rex-group | 2 |
| 171 | rips | 2 |
| 172 | self-catheterize | 2 |
| 173 | seomulyuchan | 2 |
| 174 | sham-pap | 2 |
| 175 | sligrl | 2 |
| 176 | smartsteps-only | 2 |
| 177 | sn38 | 2 |
| 178 | sphincterolysis | 2 |
| 179 | tcs2 | 2 |
| 180 | tcu380 | 2 |
| 181 | trans-autophosphorylation | 2 |
| 182 | treat=7 | 2 |
| 183 | trophins | 2 |
| 184 | trp159ala | 2 |
| 185 | ttcms | 2 |
| 186 | ziwu | 2 |
| 187 | £26 | 2 |
| 188 | β-chitin | 2 |
| 189 | €1000 | 2 |
| 190 | ∑20pcbs | 2 |
| 191 | 'cigarette | 1 |
| 192 | 'slip | 1 |
| 193 | +180° | 1 |
| 194 | +1⅓ | 1 |
| 195 | +2.00d | 1 |
| 196 | +3.53 | 1 |
| 197 | +36.6 | 1 |
| 198 | +4.93 | 1 |
| 199 | +5·2 | 1 |
| 200 | +9.20 | 1 |
| 201 | -0.0.18 | 1 |
| 202 | -0.009mm | 1 |
| 203 | -0.02526 | 1 |
| 204 | -0.11+/-0.04 | 1 |
| 205 | -0.163 | 1 |
| 206 | -0.2066 | 1 |
| 207 | -0.558 | 1 |
| 208 | -0.76v | 1 |
| 209 | -0.850 | 1 |
| 210 | -1,429 | 1 |
| 211 | -1.049 | 1 |
| 212 | -10.3/h | 1 |
| 213 | -103.3 | 1 |
| 214 | -106.87 | 1 |
| 215 | -116.39 | 1 |
| 216 | -117.42 | 1 |
| 217 | -11‰ | 1 |
| 218 | -137.62 | 1 |
| 219 | -138.96 | 1 |
| 220 | -15.58 | 1 |
| 221 | -16.59 | 1 |
| 222 | -17.48 | 1 |
| 223 | -195.67 | 1 |
| 224 | -197.54 | 1 |
| 225 | -2.00+/-0.3 | 1 |
| 226 | -2.339 | 1 |
| 227 | -207.92 | 1 |
| 228 | -212.89 | 1 |
| 229 | -213 | 1 |
| 230 | -22.9±0.3°c | 1 |
| 231 | -224.7 | 1 |
| 232 | -257.69 | 1 |
| 233 | -25°c | 1 |
| 234 | -261.52 | 1 |
| 235 | -265.95 | 1 |
| 236 | -27.07 | 1 |
| 237 | -27.32 | 1 |
| 238 | -27.72 | 1 |
| 239 | -27.79 | 1 |
| 240 | -27.82 | 1 |
| 241 | -279.51 | 1 |
| 242 | -28.90 | 1 |
| 243 | -29.77 | 1 |
| 244 | -30.36 | 1 |
| 245 | -300.82 | 1 |
| 246 | -32.40 | 1 |
| 247 | -33.96 | 1 |
| 248 | -35.04 | 1 |
| 249 | -35.49 | 1 |
| 250 | -3f | 1 |
| 251 | -41.66 | 1 |
| 252 | -42.63 | 1 |
| 253 | -42.78 | 1 |
| 254 | -45.62 | 1 |
| 255 | -5.408 | 1 |
| 256 | -65.63 | 1 |
| 257 | -65.89 | 1 |
| 258 | -67.7±1.8mv | 1 |
| 259 | -702 | 1 |
| 260 | -78.13 | 1 |
| 261 | -78.90 | 1 |
| 262 | -8.14 | 1 |
| 263 | -8h | 1 |
| 264 | -9.07 | 1 |
| 265 | -97.47 | 1 |
| 266 | -spadi- | 1 |
| 267 | -ssh | 1 |
| 268 | -£477 | 1 |
| 269 | 0-placebo | 1 |
| 270 | 0.000016 | 1 |
| 271 | 0.00229 | 1 |
| 272 | 0.00337 | 1 |
| 273 | 0.00399 | 1 |
| 274 | 0.01/min | 1 |
| 275 | 0.049mg/ml | 1 |
| 276 | 0.10+/-0.04 | 1 |
| 277 | 0.11db/nm | 1 |
| 278 | 0.12+/-0.07 | 1 |
| 279 | 0.1212 | 1 |
| 280 | 0.1455 | 1 |
| 281 | 0.15w/kg | 1 |
| 282 | 0.1770 | 1 |
| 283 | 0.2056 | 1 |
| 284 | 0.244μm | 1 |
| 285 | 0.2651 | 1 |
| 286 | 0.2nm | 1 |
| 287 | 0.3151 | 1 |
| 288 | 0.36±0.05 | 1 |
| 289 | 0.39±0.22 | 1 |
| 290 | 0.40+/-0.11 | 1 |
| 291 | 0.40-0.50mg/kg/day | 1 |
| 292 | 0.42/patient | 1 |
| 293 | 0.44+/-0.10 | 1 |
| 294 | 0.5178 | 1 |
| 295 | 0.56+/-0.08 | 1 |
| 296 | 0.60±0.33 | 1 |
| 297 | 0.6logcfu/ml | 1 |
| 298 | 0.74-fold | 1 |
| 299 | 0.74/patient | 1 |
| 300 | 0.81nmol/min/mg | 1 |
| 301 | 0.8304 | 1 |
| 302 | 0.86+/-0.04 | 1 |
| 303 | 0.8940 | 1 |
| 304 | 0.91±0.29 | 1 |
| 305 | 0.93±0.27μg/ml | 1 |
| 306 | 0.96.however | 1 |
| 307 | 0.9807 | 1 |
| 308 | 01/01/2014 | 1 |
| 309 | 01/11 | 1 |
| 310 | 02/11/94 | 1 |
| 311 | 04/2010 | 1 |
| 312 | 05/2006 | 1 |
| 313 | 06/2001 | 1 |
| 314 | 08/2010 | 1 |
| 315 | 09-jan-2009 | 1 |
| 316 | 09/2001 | 1 |
| 317 | 1,08 | 1 |
| 318 | 1,110.12 | 1 |
| 319 | 1,265.03 | 1 |
| 320 | 1,382/100,000 | 1 |
| 321 | 1,4,16-pregnatriene-3,20-diones | 1 |
| 322 | 1.00±0.52 | 1 |
| 323 | 1.0134 | 1 |
| 324 | 1.0848 | 1 |
| 325 | 1.1020 | 1 |
| 326 | 1.1208 | 1 |
| 327 | 1.2323 | 1 |
| 328 | 1.25µl/ml | 1 |
| 329 | 1.27±0.42 | 1 |
| 330 | 1.2±0.06 | 1 |
| 331 | 1.322 | 1 |
| 332 | 1.3441 | 1 |
| 333 | 1.35m | 1 |
| 334 | 1.388 | 1 |
| 335 | 1.44+/-0.44 | 1 |
| 336 | 1.54nmol/min/mg | 1 |
| 337 | 1.735 | 1 |
| 338 | 1.844 | 1 |
| 339 | 1.90±0.29 | 1 |
| 340 | 1.93-4.55 | 1 |
| 341 | 1.93±0.62 | 1 |
| 342 | 1.93±0.63 | 1 |
| 343 | 1.9410 | 1 |
| 344 | 1.94±0.34† | 1 |
| 345 | 1.9kg | 1 |
| 346 | 1/1,000,000 | 1 |
| 347 | 1/6/2009 | 1 |
| 348 | 1/radius | 1 |
| 349 | 10,809 | 1 |
| 350 | 10-30-2010 | 1 |
| 351 | 10-yearolds | 1 |
| 352 | 10.254 | 1 |
| 353 | 10.77kda | 1 |
| 354 | 10/12001 | 1 |
| 355 | 10/2001 | 1 |
| 356 | 10/2010 | 1 |
| 357 | 100×10/l | 1 |
| 358 | 101.28 | 1 |
| 359 | 101.4°f | 1 |
| 360 | 101.57 | 1 |
| 361 | 101±26 | 1 |
| 362 | 107.24 | 1 |
| 363 | 10782 | 1 |
| 364 | 107±17 | 1 |
| 365 | 108.84 | 1 |
| 366 | 109°c | 1 |
| 367 | 11.5-4 | 1 |
| 368 | 11.981 | 1 |
| 369 | 11/19/93 | 1 |
| 370 | 1107.76μg/mlh | 1 |
| 371 | 112.4°c | 1 |
| 372 | 112.56 | 1 |
| 373 | 112°c | 1 |
| 374 | 114.70 | 1 |
| 375 | 1150°c | 1 |
| 376 | 1162+/-79mg | 1 |
| 377 | 117- | 1 |
| 378 | 117.24+/-27.21ms | 1 |
| 379 | 117.89 | 1 |
| 380 | 117.9±1.3 | 1 |
| 381 | 118.41+/-21.34ms | 1 |
| 382 | 11q21q23 | 1 |
| 383 | 11q22.3-q23 | 1 |
| 384 | 11μm | 1 |
| 385 | 12.2+/-4.0 | 1 |
| 386 | 12.3+/-4 | 1 |
| 387 | 12.407 | 1 |
| 388 | 12.5mg/ml | 1 |
| 389 | 12/15/2012 | 1 |
| 390 | 12/1999 | 1 |
| 391 | 12/22/09 | 1 |
| 392 | 12/31/2007 | 1 |
| 393 | 12/31/2009 | 1 |
| 394 | 12/31/2010 | 1 |
| 395 | 120/ml | 1 |
| 396 | 121.6±8.2 | 1 |
| 397 | 12300 | 1 |
| 398 | 125.79 | 1 |
| 399 | 1254.96 | 1 |
| 400 | 12º | 1 |
| 401 | 13,928 | 1 |
| 402 | 13.03°c | 1 |
| 403 | 13.48+/-1.79 | 1 |
| 404 | 13.824 | 1 |
| 405 | 13.8±13.1 | 1 |
| 406 | 132-h-olds | 1 |
| 407 | 134.14 | 1 |
| 408 | 13600 | 1 |
| 409 | 14.1±4 | 1 |
| 410 | 14.3±4.9 | 1 |
| 411 | 140,350 | 1 |
| 412 | 147/88 | 1 |
| 413 | 15.64μm | 1 |
| 414 | 154° | 1 |
| 415 | 156.9/81.5 | 1 |
| 416 | 156°c | 1 |
| 417 | 157.15 | 1 |
| 418 | 15asb | 1 |
| 419 | 16.10€ | 1 |
| 420 | 16.83±4.73 | 1 |
| 421 | 167.85 | 1 |
| 422 | 1691µv | 1 |
| 423 | 16q21 | 1 |
| 424 | 17.004 | 1 |
| 425 | 17.5±2.6 | 1 |
| 426 | 17/ml | 1 |
| 427 | 170/100,000 | 1 |
| 428 | 172.11 | 1 |
| 429 | 175° | 1 |
| 430 | 179.29 | 1 |
| 431 | 17alpha-cyanomethyl-estradoil-3-methylether | 1 |
| 432 | 18-yr-olds | 1 |
| 433 | 18.0:1 | 1 |
| 434 | 18.17°c | 1 |
| 435 | 18.5±7.4 | 1 |
| 436 | 18.72±0.78μg/ml | 1 |
| 437 | 1833.69 | 1 |
| 438 | 18381+/-1772 | 1 |
| 439 | 187.74 | 1 |
| 440 | 189.27+/-28.49ms | 1 |
| 441 | 189.37 | 1 |
| 442 | 19.4±3.8 | 1 |
| 443 | 19.9±27.5ng/ml | 1 |
| 444 | 199.37 | 1 |
| 445 | 1:0.3 | 1 |
| 446 | 1:2569 | 1 |
| 447 | 1:90 | 1 |
| 448 | 1∶160 | 1 |
| 449 | 2'-amp/3'-amp | 1 |
| 450 | 2,3-dihydroazetes | 1 |
| 451 | 2,5-furandimethanol | 1 |
| 452 | 2,6-disubstitution | 1 |
| 453 | 2-acetolactate | 1 |
| 454 | 2-aryl-2,5-dihydro-1h-pyrroles | 1 |
| 455 | 2-methylpyrroline | 1 |
| 456 | 2.0035 | 1 |
| 457 | 2.05±0.29 | 1 |
| 458 | 2.0z | 1 |
| 459 | 2.1ppmv | 1 |
| 460 | 2.28mg/ml | 1 |
| 461 | 2.2±2.4mg/l | 1 |
| 462 | 2.30ng/l | 1 |
| 463 | 2.37±0.79 | 1 |
| 464 | 2.3±2.0pg/ml | 1 |
| 465 | 2.474 | 1 |
| 466 | 2.588 | 1 |
| 467 | 2.5±1.3 | 1 |
| 468 | 2.660 | 1 |
| 469 | 2.718 | 1 |
| 470 | 2.738 | 1 |
| 471 | 2.739 | 1 |
| 472 | 2.8±1.6 | 1 |
| 473 | 2.918 | 1 |
| 474 | 2/2010 | 1 |
| 475 | 20/2000 | 1 |
| 476 | 2000/02 | 1 |
| 477 | 2003-02 | 1 |
| 478 | 2005/12/31 | 1 |
| 479 | 2007/12/31 | 1 |
| 480 | 2010–2011 | 1 |
| 481 | 2013/06 | 1 |
| 482 | 2048µg/ml | 1 |
| 483 | 20ppm | 1 |
| 484 | 21,956 | 1 |
| 485 | 21.60+/-10.18 | 1 |
| 486 | 21.70+/-9.61 | 1 |
| 487 | 212.78 | 1 |
| 488 | 212.9 | 1 |
| 489 | 2120ml/min | 1 |
| 490 | 219,775 | 1 |
| 491 | 22.36µg/ml | 1 |
| 492 | 222.054 | 1 |
| 493 | 2245°c | 1 |
| 494 | 225±137pg/ml | 1 |
| 495 | 22nm | 1 |
| 496 | 23,679 | 1 |
| 497 | 231.0+/-3.2mg/dl | 1 |
| 498 | 231.51 | 1 |
| 499 | 231.84 | 1 |
| 500 | 23±1 | 1 |
| 501 | 24-years-old | 1 |
| 502 | 2400nm | 1 |
| 503 | 245,724 | 1 |
| 504 | 245°c | 1 |
| 505 | 247° | 1 |
| 506 | 24:58 | 1 |
| 507 | 24years | 1 |
| 508 | 25.140 | 1 |
| 509 | 25.94μm | 1 |
| 510 | 250,286 | 1 |
| 511 | 2510.0 | 1 |
| 512 | 2559.2 | 1 |
| 513 | 26,439euro/qaly | 1 |
| 514 | 26.8±4 | 1 |
| 515 | 260.49 | 1 |
| 516 | 262,567 | 1 |
| 517 | 263°c | 1 |
| 518 | 27/11/09 | 1 |
| 519 | 278±14nmol/l | 1 |
| 520 | 27mev | 1 |
| 521 | 28.46±8.24nmol/μg/h | 1 |
| 522 | 280mg/dl | 1 |
| 523 | 2895.53mg | 1 |
| 524 | 28nm | 1 |
| 525 | 29.1+/-1.4 | 1 |
| 526 | 29.7delta | 1 |
| 527 | 290bp | 1 |
| 528 | 291.82 | 1 |
| 529 | 296.4 | 1 |
| 530 | 2gy×30 | 1 |
| 531 | 3,067 | 1 |
| 532 | 3,4,3',4'-tetrahydrospirilloxanthin | 1 |
| 533 | 3,4-dihydrocoumarins | 1 |
| 534 | 3-day-plaque-regrowth-interval | 1 |
| 535 | 3-xorsat | 1 |
| 536 | 3.345 | 1 |
| 537 | 3.36°c | 1 |
| 538 | 3.37±0.9 | 1 |
| 539 | 3.464 | 1 |
| 540 | 3.485 | 1 |
| 541 | 3.53-fold | 1 |
| 542 | 3.5nm | 1 |
| 543 | 3.5μg/day | 1 |
| 544 | 3.6±1.0 | 1 |
| 545 | 3.772 | 1 |
| 546 | 3.7±1.8 | 1 |
| 547 | 3.816 | 1 |
| 548 | 3/fistula | 1 |
| 549 | 30.12.2011 | 1 |
| 550 | 30/08/2012 | 1 |
| 551 | 30/october/2013 | 1 |
| 552 | 300kgy | 1 |
| 553 | 301.08 | 1 |
| 554 | 302±15nmol/l | 1 |
| 555 | 30±6kg/m2 | 1 |
| 556 | 31+/-18 | 1 |
| 557 | 31-12-94 | 1 |
| 558 | 31.3+/-3.1 | 1 |
| 559 | 31.3±6.8 | 1 |
| 560 | 31/10/2001 | 1 |
| 561 | 31/7/2007 | 1 |
| 562 | 310k | 1 |
| 563 | 31±1.8ms | 1 |
| 564 | 32.2ml | 1 |
| 565 | 327±88u.carr | 1 |
| 566 | 33.3±2.89 | 1 |
| 567 | 337.785±84.504 | 1 |
| 568 | 34.713 | 1 |
| 569 | 3420bp | 1 |
| 570 | 343.9 | 1 |
| 571 | 35-29°c | 1 |
| 572 | 350ms | 1 |
| 573 | 37/hr | 1 |
| 574 | 3700m | 1 |
| 575 | 38,921€ | 1 |
| 576 | 38.3℃ | 1 |
| 577 | 38.5μm | 1 |
| 578 | 38.7dgc | 1 |
| 579 | 383.97 | 1 |
| 580 | 386.6 | 1 |
| 581 | 393.66 | 1 |
| 582 | 3β-acetoxy-16-methylene-androst-5-en-17-one | 1 |
| 583 | 4-6-month-old | 1 |
| 584 | 4-8/4-16 | 1 |
| 585 | 4-hydroxyphenylglyoxylate | 1 |
| 586 | 4-methylvalerate | 1 |
| 587 | 4.0/1.9 | 1 |
| 588 | 4.007 | 1 |
| 589 | 4.112 | 1 |
| 590 | 4.4+/-0.7 | 1 |
| 591 | 4.5-6g | 1 |
| 592 | 4.58°c | 1 |
| 593 | 4.5mmhg | 1 |
| 594 | 4/30/2010 | 1 |
| 595 | 40-60g | 1 |
| 596 | 4000mg/l | 1 |
| 597 | 403.99 | 1 |
| 598 | 405/100,000 | 1 |
| 599 | 409.3 | 1 |
| 600 | 40k/min | 1 |
| 601 | 40°c/exh | 1 |
| 602 | 40°s | 1 |
| 603 | 41,7ºc | 1 |
| 604 | 414-fold | 1 |
| 605 | 43.3+/-3.4 | 1 |
| 606 | 43.3±29.1 | 1 |
| 607 | 44.7°±12.3° | 1 |
| 608 | 44/80 | 1 |
| 609 | 4479 | 1 |
| 610 | 45.1+/-9.7 | 1 |
| 611 | 45.4±0.9 | 1 |
| 612 | 46+/-18 | 1 |
| 613 | 46.0fg | 1 |
| 614 | 46.80€ | 1 |
| 615 | 47,600ppm | 1 |
| 616 | 48-years-old | 1 |
| 617 | 48.0pg/ml | 1 |
| 618 | 49.4±21.0µmol/l | 1 |
| 619 | 4·04 | 1 |
| 620 | 5-fu/rt | 1 |
| 621 | 5.0/20 | 1 |
| 622 | 5.00°c | 1 |
| 623 | 5.1/100py | 1 |
| 624 | 5.14+/-2 | 1 |
| 625 | 5.1997 | 1 |
| 626 | 5.1:1 | 1 |
| 627 | 5.21°c | 1 |
| 628 | 5.2°c | 1 |
| 629 | 5.34-fold | 1 |
| 630 | 5.354 | 1 |
| 631 | 5.36+/-0.61 | 1 |
| 632 | 5.3702 | 1 |
| 633 | 5.446 | 1 |
| 634 | 5.5±4.9ng/ml | 1 |
| 635 | 5.7× | 1 |
| 636 | 5.858 | 1 |
| 637 | 5.935 | 1 |
| 638 | 5000.00ng/ml | 1 |
| 639 | 53.1°c | 1 |
| 640 | 5355±1257/µl | 1 |
| 641 | 537.52 | 1 |
| 642 | 55.68 | 1 |
| 643 | 55.72 | 1 |
| 644 | 55/hr | 1 |
| 645 | 55nm | 1 |
| 646 | 56.5/100,000 | 1 |
| 647 | 560°c | 1 |
| 648 | 56h | 1 |
| 649 | 56±35 | 1 |
| 650 | 57,460 | 1 |
| 651 | 57.6±4.1 | 1 |
| 652 | 575k | 1 |
| 653 | 58.2/100,000/year | 1 |
| 654 | 58.4g/l | 1 |
| 655 | 58.9-fold | 1 |
| 656 | 59.5°c | 1 |
| 657 | 5=difficult | 1 |
| 658 | 5x10-4 | 1 |
| 659 | 5°c/h | 1 |
| 660 | 5α-androstanedione-3,17-dione | 1 |
| 661 | 6-oxygen | 1 |
| 662 | 6.00/1000 | 1 |
| 663 | 6.0±3.1 | 1 |
| 664 | 6.684 | 1 |
| 665 | 6.94±4.02 | 1 |
| 666 | 6/2012 | 1 |
| 667 | 60.39 | 1 |
| 668 | 61.10 | 1 |
| 669 | 64.6±23.6 | 1 |
| 670 | 65.4ppmv | 1 |
| 671 | 65.935 | 1 |
| 672 | 675.5 | 1 |
| 673 | 676nm | 1 |
| 674 | 68.95 | 1 |
| 675 | 694.1 | 1 |
| 676 | 6m/s | 1 |
| 677 | 7,253€ | 1 |
| 678 | 7.215 | 1 |
| 679 | 7.6+/-2.8 | 1 |
| 680 | 7.789 | 1 |
| 681 | 7.7nm | 1 |
| 682 | 7.97+/-0.85 | 1 |
| 683 | 7.9±2.8 | 1 |
| 684 | 7/1/2013 | 1 |
| 685 | 706.74 | 1 |
| 686 | 71.20 | 1 |
| 687 | 71.3m | 1 |
| 688 | 71.570±4.324μg/ml | 1 |
| 689 | 71.72°c | 1 |
| 690 | 72min | 1 |
| 691 | 72±8beats/min | 1 |
| 692 | 73.8±23.3µmol/l | 1 |
| 693 | 75,500/µl | 1 |
| 694 | 76.50 | 1 |
| 695 | 77.26 | 1 |
| 696 | 78+/-8mmhg | 1 |
| 697 | 78.02 | 1 |
| 698 | 78°c≈tm | 1 |
| 699 | 794aa | 1 |
| 700 | 7mer | 1 |
| 701 | 7·09 | 1 |
| 702 | 8-10cmh2o | 1 |
| 703 | 8-nitroguanosine | 1 |
| 704 | 8.2/10 | 1 |
| 705 | 8.334 | 1 |
| 706 | 8.5×1011b | 1 |
| 707 | 8.67±2.13 | 1 |
| 708 | 8.7/micromol/l | 1 |
| 709 | 8.741 | 1 |
| 710 | 8.7±2.5 | 1 |
| 711 | 80.22 | 1 |
| 712 | 80µg/day | 1 |
| 713 | 81- | 1 |
| 714 | 8167±3111 | 1 |
| 715 | 84.4kg | 1 |
| 716 | 85.6.8+/-7.6mg | 1 |
| 717 | 8512 | 1 |
| 718 | 86.35µg/ml | 1 |
| 719 | 869,250 | 1 |
| 720 | 88.70 | 1 |
| 721 | 886.3 | 1 |
| 722 | 9-oh-add | 1 |
| 723 | 9.0m | 1 |
| 724 | 9.73μm | 1 |
| 725 | 9.therefore | 1 |
| 726 | 9/30/12 | 1 |
| 727 | 9/h | 1 |
| 728 | 90+°c | 1 |
| 729 | 90.96 | 1 |
| 730 | 92.0±40.5mmol/l | 1 |
| 731 | 93.1°c | 1 |
| 732 | 93.6°c | 1 |
| 733 | 94.0°c | 1 |
| 734 | 95.5º | 1 |
| 735 | 9596±3907 | 1 |
| 736 | 96hour | 1 |
| 737 | 97kw | 1 |
| 738 | 98.5±28.1 | 1 |
| 739 | 99.3±15.1μmol/min/ml | 1 |
| 740 | a.oryzoe | 1 |
| 741 | a.r | 1 |
| 742 | a/duck/quangngai/1037/2011 | 1 |
| 743 | a=135 | 1 |
| 744 | aa-subjects | 1 |
| 745 | acclimatisation/adaptation | 1 |
| 746 | acetopyruvate | 1 |
| 747 | acetycholine | 1 |
| 748 | achsp70 | 1 |
| 749 | acidiphilic | 1 |
| 750 | acra8 | 1 |
| 751 | adaptation/habituation | 1 |
| 752 | ademe-thionine | 1 |
| 753 | adenotonsilectomy | 1 |
| 754 | administer.thus | 1 |
| 755 | adoprazine | 1 |
| 756 | adults.moreover | 1 |
| 757 | aerofluxus | 1 |
| 758 | aflp4 | 1 |
| 759 | al-hada | 1 |
| 760 | aldophosphamide | 1 |
| 761 | alkoxypropanols | 1 |
| 762 | alprazolam-exposure | 1 |
| 763 | alr-5iia-1-1 | 1 |
| 764 | amdo | 1 |
| 765 | aminodinitrotoluenes | 1 |
| 766 | amoxicillin-clavunanic | 1 |
| 767 | anareolineales | 1 |
| 768 | ang-i | 1 |
| 769 | angiographic-guided | 1 |
| 770 | annelida-dominated | 1 |
| 771 | antero-septum | 1 |
| 772 | anthropopressure | 1 |
| 773 | antibioterrorism | 1 |
| 774 | application-oriented | 1 |
| 775 | aquarists | 1 |
| 776 | arg346 | 1 |
| 777 | argonaute-2 | 1 |
| 778 | asthenoteratospermia | 1 |
| 779 | asthmagens | 1 |
| 780 | atenolol/bendroflumethiazide | 1 |
| 781 | attempts-much | 1 |
| 782 | attention/default-mode | 1 |
| 783 | at→cmf | 1 |
| 784 | autoinfection | 1 |
| 785 | azepanium | 1 |
| 786 | azt-backbones | 1 |
| 787 | b-albumin | 1 |
| 788 | barc-3b | 1 |
| 789 | baseline/mp | 1 |
| 790 | bhubaneswar | 1 |
| 791 | biodiesels-wsf | 1 |
| 792 | blumberger | 1 |
| 793 | bottlefeeding | 1 |
| 794 | brickworks | 1 |
| 795 | bronchoconstrict | 1 |
| 796 | bronchosecretolytics | 1 |
| 797 | c-cbl | 1 |
| 798 | c52 | 1 |
| 799 | c57black6 | 1 |
| 800 | c6s | 1 |
| 801 | calbicans | 1 |
| 802 | calculed | 1 |
| 803 | cancerous-tissues | 1 |
| 804 | carbapenemics | 1 |
| 805 | cardiocentre | 1 |
| 806 | cardiomyoctyes | 1 |
| 807 | carvedilol.6 | 1 |
| 808 | cdai/sdai | 1 |
| 809 | cellularize | 1 |
| 810 | cephtizoxin | 1 |
| 811 | cerebrovasculopathy | 1 |
| 812 | cervugid-ovules | 1 |
| 813 | cgp37157 | 1 |
| 814 | chaetonotida | 1 |
| 815 | chemoimmobilisation | 1 |
| 816 | chlormphenicol | 1 |
| 817 | chondroitin-4-sulphate | 1 |
| 818 | chr-1 | 1 |
| 819 | cineangiocoronarography | 1 |
| 820 | ciproflaxacine | 1 |
| 821 | cirrhosis-hcc | 1 |
| 822 | cisplatinum-5-fluoro-uracile | 1 |
| 823 | citrus-like | 1 |
| 824 | clandes-tine | 1 |
| 825 | clavate | 1 |
| 826 | cldn-1- | 1 |
| 827 | clear-white | 1 |
| 828 | cmt1 | 1 |
| 829 | co-classify | 1 |
| 830 | co-create | 1 |
| 831 | colerin | 1 |
| 832 | colisepticaemia | 1 |
| 833 | conditioned-cues | 1 |
| 834 | control-hdl | 1 |
| 835 | control/waiting-list | 1 |
| 836 | corticoid-therapy | 1 |
| 837 | cowardice | 1 |
| 838 | cpap.new | 1 |
| 839 | cpl1/fiery2 | 1 |
| 840 | craig-walker | 1 |
| 841 | cris-153 | 1 |
| 842 | ctx-injection | 1 |
| 843 | culture-result | 1 |
| 844 | cuproenzymes | 1 |
| 845 | cuteness | 1 |
| 846 | cys-orthologues | 1 |
| 847 | cys191 | 1 |
| 848 | c₆₄ | 1 |
| 849 | d-glcp | 1 |
| 850 | d-penicillamine-like | 1 |
| 851 | d0/1-dissection | 1 |
| 852 | d14-3-3ε | 1 |
| 853 | d2cc | 1 |
| 854 | d365 | 1 |
| 855 | day14 | 1 |
| 856 | december-2010 | 1 |
| 857 | december-2011 | 1 |
| 858 | december/2009 | 1 |
| 859 | december/94 | 1 |
| 860 | december，1995 | 1 |
| 861 | defragmented | 1 |
| 862 | deliquesce | 1 |
| 863 | delivery.results | 1 |
| 864 | dexamethasone.there | 1 |
| 865 | diabetes.acarbose | 1 |
| 866 | dihydroquinones | 1 |
| 867 | dimethylacrylamide | 1 |
| 868 | disc/fovea | 1 |
| 869 | drb3- | 1 |
| 870 | dtdp-3-keto-6-deoxyglucose | 1 |
| 871 | dyserythopoiesis | 1 |
| 872 | e2-3,4-quinone | 1 |
| 873 | eachketena | 1 |
| 874 | ecasa+c | 1 |
| 875 | eclose | 1 |
| 876 | eds-analysis | 1 |
| 877 | efmtool | 1 |
| 878 | en/iso | 1 |
| 879 | endolysins | 1 |
| 880 | endomondo.com | 1 |
| 881 | endovasculature | 1 |
| 882 | enets-tnm | 1 |
| 883 | epimerize | 1 |
| 884 | er-a | 1 |
| 885 | er/pr+tumors | 1 |
| 886 | ergosteryl-3β-glucoside | 1 |
| 887 | erlotinib/hcq | 1 |
| 888 | euro122 | 1 |
| 889 | euro28,000 | 1 |
| 890 | events-angiographic | 1 |
| 891 | exemptors | 1 |
| 892 | extensiometry | 1 |
| 893 | fac6 | 1 |
| 894 | face-to-face-programming | 1 |
| 895 | face/telephone | 1 |
| 896 | fansler-arnold | 1 |
| 897 | fatigue/nausea | 1 |
| 898 | fe2+-heme | 1 |
| 899 | fecosterol | 1 |
| 900 | fefdbi | 1 |
| 901 | fhb-resistance | 1 |
| 902 | fhcd59-1.7 | 1 |
| 903 | finnger | 1 |
| 904 | flatus/feces | 1 |
| 905 | fluorimeters | 1 |
| 906 | follow-up.overall | 1 |
| 907 | follow-up/withdrawals | 1 |
| 908 | fra3b | 1 |
| 909 | gatifloxacine | 1 |
| 910 | gaze-assistance | 1 |
| 911 | gb16889-2008 | 1 |
| 912 | gonzales-crussi | 1 |
| 913 | h.n | 1 |
| 914 | h266 | 1 |
| 915 | haemos | 1 |
| 916 | hanatoxin | 1 |
| 917 | handihaler™ | 1 |
| 918 | hb-21 | 1 |
| 919 | hb-koln | 1 |
| 920 | hcv/treatment | 1 |
| 921 | heart-failure-patients | 1 |
| 922 | heat.2 | 1 |
| 923 | helmintiasis | 1 |
| 924 | hemadsorb | 1 |
| 925 | hepta-bdes | 1 |
| 926 | hexacoordination | 1 |
| 927 | hfd+placebo | 1 |
| 928 | hfd-control | 1 |
| 929 | hgd/adenocarcinoma | 1 |
| 930 | hgkrp | 1 |
| 931 | hierarchist | 1 |
| 932 | high-expected-benefit | 1 |
| 933 | high/normal | 1 |
| 934 | hiv-1-rt | 1 |
| 935 | hivp24 | 1 |
| 936 | homodimerize | 1 |
| 937 | housekeep | 1 |
| 938 | hph1 | 1 |
| 939 | hsp110-like | 1 |
| 940 | htg6 | 1 |
| 941 | hunt-lawrence-rodino | 1 |
| 942 | hypertension/dyslipidaemia | 1 |
| 943 | hypo-vitaminosis | 1 |
| 944 | hypoxia-re-oxygenation | 1 |
| 945 | ie2 | 1 |
| 946 | ifn-α-stimulation | 1 |
| 947 | ifnalpha-2b | 1 |
| 948 | ifosfamide/heat | 1 |
| 949 | ih-c₆₀ | 1 |
| 950 | ii-ii | 1 |
| 951 | imipenum | 1 |
| 952 | immunity/defence | 1 |
| 953 | incinerate | 1 |
| 954 | injection-aspiration | 1 |
| 955 | internet/blogs | 1 |
| 956 | iodine-deficiency | 1 |
| 957 | iso-amyl-cyanoacrylate | 1 |
| 958 | isolg-ethanolamine | 1 |
| 959 | isoviscous | 1 |
| 960 | itrazonazole | 1 |
| 961 | ivbor | 1 |
| 962 | january1 | 1 |
| 963 | jiejian | 1 |
| 964 | june2014 | 1 |
| 965 | jírovec | 1 |
| 966 | k.b.a | 1 |
| 967 | k.n. | 1 |
| 968 | kadir | 1 |
| 969 | ken-a | 1 |
| 970 | krimmer | 1 |
| 971 | l-halotryptophans | 1 |
| 972 | l10f | 1 |
| 973 | lack-of-efficacy | 1 |
| 974 | late-1990s | 1 |
| 975 | leonhard | 1 |
| 976 | levcromakalim | 1 |
| 977 | level-walking | 1 |
| 978 | li-diffusion | 1 |
| 979 | libaf3 | 1 |
| 980 | liberase-hi | 1 |
| 981 | lights-off | 1 |
| 982 | lignocellulases | 1 |
| 983 | lithium/valproate/carbamazepine | 1 |
| 984 | loc_os06g226100 | 1 |
| 985 | locally-generated | 1 |
| 986 | loe-5 | 1 |
| 987 | lynchpins | 1 |
| 988 | lysosomes/autolysosomes | 1 |
| 989 | m173 | 1 |
| 990 | m=1.27 | 1 |
| 991 | macrodasyida | 1 |
| 992 | mainframes | 1 |
| 993 | mandibulata | 1 |
| 994 | mandya | 1 |
| 995 | mar.2013 | 1 |
| 996 | march-2013 | 1 |
| 997 | march/97 | 1 |
| 998 | marcus.currently | 1 |
| 999 | martentoxin | 1 |
| 1000 | mastreviruses | 1 |
| 1001 | mdct/mr | 1 |
| 1002 | me/pathophysiology | 1 |
| 1003 | metamyelocytes | 1 |
| 1004 | methanediazohydroxide | 1 |
| 1005 | metula | 1 |
| 1006 | metylphenidate | 1 |
| 1007 | mevalonate-3-phosphate | 1 |
| 1008 | mex3c | 1 |
| 1009 | mf-mpi | 1 |
| 1010 | micron-sizes | 1 |
| 1011 | microphlypnus | 1 |
| 1012 | microspherocytes | 1 |
| 1013 | mild/none | 1 |
| 1014 | mini-hlm-revascularisation | 1 |
| 1015 | misjudgment | 1 |
| 1016 | mitxantrone | 1 |
| 1017 | mn-gtp | 1 |
| 1018 | monochromatization | 1 |
| 1019 | mopotsyo | 1 |
| 1020 | mrt2* | 1 |
| 1021 | mucosecretion | 1 |
| 1022 | multi-peaks | 1 |
| 1023 | multidrugs | 1 |
| 1024 | mvbs/lysosomes | 1 |
| 1025 | myalgia-myopathy | 1 |
| 1026 | myocardiacyte | 1 |
| 1027 | mzimba | 1 |
| 1028 | n-sulfonylaziridines | 1 |
| 1029 | na-processing | 1 |
| 1030 | nazzi | 1 |
| 1031 | ne/erp-variability | 1 |
| 1032 | nestmates | 1 |
| 1033 | neutral/menthol | 1 |
| 1034 | never-drinkers | 1 |
| 1035 | ni/w/sba-15 | 1 |
| 1036 | nicu/hospital | 1 |
| 1037 | nitrofuraintoin | 1 |
| 1038 | no-tvt | 1 |
| 1039 | no-ufh | 1 |
| 1040 | non-anticipation | 1 |
| 1041 | non-avoidance | 1 |
| 1042 | non-chemists | 1 |
| 1043 | non-crossovers | 1 |
| 1044 | non-oestrogen-treated | 1 |
| 1045 | non-persistency | 1 |
| 1046 | non-pharmacodynamic | 1 |
| 1047 | non-suicides | 1 |
| 1048 | non-thermophiles | 1 |
| 1049 | non-warmed | 1 |
| 1050 | nonamputees | 1 |
| 1051 | nonsubjects | 1 |
| 1052 | nonteratogens | 1 |
| 1053 | normal.3 | 1 |
| 1054 | nprup3 | 1 |
| 1055 | ntng | 1 |
| 1056 | nylen | 1 |
| 1057 | nε-hcy-proteins | 1 |
| 1058 | n∼45,000 | 1 |
| 1059 | okt3/atg | 1 |
| 1060 | oligoamucorrhea | 1 |
| 1061 | ophiocara | 1 |
| 1062 | osmoregulate | 1 |
| 1063 | ovalocytosis | 1 |
| 1064 | overcollecting | 1 |
| 1065 | overconsume | 1 |
| 1066 | overdrink | 1 |
| 1067 | oxalyl-coa | 1 |
| 1068 | p38-blockade | 1 |
| 1069 | p495-mutations | 1 |
| 1070 | packers | 1 |
| 1071 | paired-tms | 1 |
| 1072 | pakg | 1 |
| 1073 | pam-nt3 | 1 |
| 1074 | paracrine-driven | 1 |
| 1075 | paraphymosis | 1 |
| 1076 | partington-rochelle | 1 |
| 1077 | passeriforms | 1 |
| 1078 | patients'or | 1 |
| 1079 | patients'sex | 1 |
| 1080 | pcos-controls | 1 |
| 1081 | pentanethiol | 1 |
| 1082 | pep-speech | 1 |
| 1083 | pgy-6 | 1 |
| 1084 | phocomelia | 1 |
| 1085 | phonate | 1 |
| 1086 | photo-sensibilization | 1 |
| 1087 | photonlike | 1 |
| 1088 | pinch/pressure | 1 |
| 1089 | pio+lacebo | 1 |
| 1090 | plabebo | 1 |
| 1091 | placebo.finally | 1 |
| 1092 | placebo.however | 1 |
| 1093 | placebo/dextran | 1 |
| 1094 | play/study | 1 |
| 1095 | pleurocapsales | 1 |
| 1096 | plus-crossing | 1 |
| 1097 | pml-multimerization | 1 |
| 1098 | pn-n-1307:1994 | 1 |
| 1099 | pnd-21 | 1 |
| 1100 | pnd8 | 1 |
| 1101 | pod14 | 1 |
| 1102 | poeticness | 1 |
| 1103 | pollinate | 1 |
| 1104 | population/setting | 1 |
| 1105 | post-fbt | 1 |
| 1106 | post-think-aloud | 1 |
| 1107 | postdifferences | 1 |
| 1108 | pound154,752 | 1 |
| 1109 | pound400 | 1 |
| 1110 | ppatg18 | 1 |
| 1111 | pre-ect | 1 |
| 1112 | pre-ekgs | 1 |
| 1113 | pre-flow | 1 |
| 1114 | pre-rvd | 1 |
| 1115 | prerace-performance | 1 |
| 1116 | pretzel-baking | 1 |
| 1117 | pro35s | 1 |
| 1118 | procline | 1 |
| 1119 | pseudopulicidae | 1 |
| 1120 | ptca/stenting | 1 |
| 1121 | pyrazolidines | 1 |
| 1122 | pyrearinus | 1 |
| 1123 | pyrenochaeta | 1 |
| 1124 | qsy21 | 1 |
| 1125 | quadrupeds | 1 |
| 1126 | question-answering | 1 |
| 1127 | quinone- | 1 |
| 1128 | r-chop-ie | 1 |
| 1129 | rbc-membranes | 1 |
| 1130 | re-anesthetise | 1 |
| 1131 | re-operating | 1 |
| 1132 | real-timely | 1 |
| 1133 | rectitis | 1 |
| 1134 | rehberg-tareev | 1 |
| 1135 | rejection/acceptance | 1 |
| 1136 | reoperate | 1 |
| 1137 | resend | 1 |
| 1138 | response/tolerability | 1 |
| 1139 | rh0808 | 1 |
| 1140 | rs16861210 | 1 |
| 1141 | récurettage | 1 |
| 1142 | s/plc | 1 |
| 1143 | score≤60 | 1 |
| 1144 | sds-electrophoresis | 1 |
| 1145 | se-asia | 1 |
| 1146 | sedoheptulose-7-phosphate | 1 |
| 1147 | self-agglutination | 1 |
| 1148 | self-needlers | 1 |
| 1149 | self-react | 1 |
| 1150 | self-reflect | 1 |
| 1151 | self-reproduction | 1 |
| 1152 | self-vaccinate | 1 |
| 1153 | semi-reflectors | 1 |
| 1154 | semiprofile | 1 |
| 1155 | ser404 | 1 |
| 1156 | ser49/ser49 | 1 |
| 1157 | sharmanism | 1 |
| 1158 | shellfishing | 1 |
| 1159 | shelter-providing | 1 |
| 1160 | sialilation | 1 |
| 1161 | situations/problems | 1 |
| 1162 | sleeep | 1 |
| 1163 | society-low | 1 |
| 1164 | soothe/comfort | 1 |
| 1165 | spmab | 1 |
| 1166 | sr2ruo4 | 1 |
| 1167 | srascov | 1 |
| 1168 | ss-lactams | 1 |
| 1169 | sse1p | 1 |
| 1170 | st-101 | 1 |
| 1171 | st85 | 1 |
| 1172 | staggered-onset | 1 |
| 1173 | stagnate | 1 |
| 1174 | steadman | 1 |
| 1175 | steradiene | 1 |
| 1176 | subspecialize | 1 |
| 1177 | sulfamethoxazole/trimetoprim | 1 |
| 1178 | super-shedders | 1 |
| 1179 | supra-infections | 1 |
| 1180 | swelling/hydrops | 1 |
| 1181 | systematists | 1 |
| 1182 | t-13 | 1 |
| 1183 | t-family | 1 |
| 1184 | tambacunda | 1 |
| 1185 | target-screen | 1 |
| 1186 | tc+tse | 1 |
| 1187 | tcm/acupuncture | 1 |
| 1188 | teleosemantics | 1 |
| 1189 | tension/stress | 1 |
| 1190 | tethracycline | 1 |
| 1191 | tetracylines | 1 |
| 1192 | tezampanel | 1 |
| 1193 | tfeis | 1 |
| 1194 | therapeutic-modalities | 1 |
| 1195 | thioles | 1 |
| 1196 | tiamphenicol | 1 |
| 1197 | time-off-work | 1 |
| 1198 | time-to-time | 1 |
| 1199 | tinyurl.com/pggfrwn | 1 |
| 1200 | tocolyticum | 1 |
| 1201 | tom70 | 1 |
| 1202 | toxin-degradation | 1 |
| 1203 | tpr/fpr | 1 |
| 1204 | transdisciplinarity | 1 |
| 1205 | treadmill-tests | 1 |
| 1206 | treat-principle | 1 |
| 1207 | treat=11 | 1 |
| 1208 | treat=12.5 | 1 |
| 1209 | treat=16 | 1 |
| 1210 | treat=18 | 1 |
| 1211 | treat=3.22 | 1 |
| 1212 | treat=34 | 1 |
| 1213 | treat=4 | 1 |
| 1214 | treat=40 | 1 |
| 1215 | treat=5.0 | 1 |
| 1216 | treat=5.88 | 1 |
| 1217 | treat=50 | 1 |
| 1218 | tyr15 | 1 |
| 1219 | us-ncep | 1 |
| 1220 | vaginal-vault-brachytherapy | 1 |
| 1221 | vamcomycin | 1 |
| 1222 | vandalize | 1 |
| 1223 | vca-p18 | 1 |
| 1224 | vehicle-administration | 1 |
| 1225 | ventilation-perfusion-mismatch | 1 |
| 1226 | ventriculoscopy | 1 |
| 1227 | vernaculars | 1 |
| 1228 | viagra.design | 1 |
| 1229 | vincristine-doxorubicine-dexamethasone | 1 |
| 1230 | vitebsky | 1 |
| 1231 | vivonex | 1 |
| 1232 | vlcd-programs | 1 |
| 1233 | vo2max. | 1 |
| 1234 | vpa+placebo | 1 |
| 1235 | walk/cycle | 1 |
| 1236 | weight-recovery | 1 |
| 1237 | wertheim-held | 1 |
| 1238 | who/ada | 1 |
| 1239 | width-discontinuity | 1 |
| 1240 | wkw | 1 |
| 1241 | wlcs | 1 |
| 1242 | woman-centredness | 1 |
| 1243 | wood-pasture | 1 |
| 1244 | wr-ai3 | 1 |
| 1245 | wsc1/slg1/hcs77 | 1 |
| 1246 | wu-magnitude | 1 |
| 1247 | x=0.01 | 1 |
| 1248 | xenobitics-metabolizing | 1 |
| 1249 | y.k | 1 |
| 1250 | zidovudine-use | 1 |
| 1251 | ziguinchor | 1 |
| 1252 | ~9,160 | 1 |
| 1253 | £126,060 | 1 |
| 1254 | £14,959 | 1 |
| 1255 | £31,430 | 1 |
| 1256 | £4733 | 1 |
| 1257 | £590 | 1 |
| 1258 | £662 | 1 |
| 1259 | £71,902 | 1 |
| 1260 | ±4° | 1 |
| 1261 | α-fluoro- | 1 |
| 1262 | β-silyl-α | 1 |
| 1263 | β-tridymite | 1 |
| 1264 | βalanlecycmshhex | 1 |
| 1265 | μ39.5 | 1 |
| 1266 | ω-3-pufa | 1 |
| 1267 | ‒0.39 | 1 |
| 1268 | –0.35 | 1 |
| 1269 | €235.750/qaly | 1 |
| 1270 | €29,000 | 1 |
| 1271 | €3673 | 1 |
| 1272 | €42,271 | 1 |
| 1273 | −0.21 | 1 |
| 1274 | −120.19 | 1 |
| 1275 | ∼74°c | 1 |
| 1276 | ≤15ml/s | 1 |
| 1277 | ≤20/30 | 1 |
| 1278 | ≤72,000cells/ml | 1 |
| 1279 | ≤89 | 1 |
| 1280 | ≥44°c | 1 |
| 1281 | ⩽4years | 1 |
| 1 | 'cigarette | 1 |
| 2 | 'slip | 1 |
| 3 | +180° | 1 |
| 4 | +1⅓ | 1 |
| 5 | +2.00d | 1 |
| 6 | +3.53 | 1 |
| 7 | +36.6 | 1 |
| 8 | +4.93 | 1 |
| 9 | +5·2 | 1 |
| 10 | +9.20 | 1 |
| 11 | -0.0.18 | 1 |
| 12 | -0.009mm | 1 |
| 13 | -0.02526 | 1 |
| 14 | -0.11+/-0.04 | 1 |
| 15 | -0.138 | 2 |
| 16 | -0.141 | 2 |
| 17 | -0.163 | 1 |
| 18 | -0.2066 | 1 |
| 19 | -0.558 | 1 |
| 20 | -0.76v | 1 |
| 21 | -0.850 | 1 |
| 22 | -1,429 | 1 |
| 23 | -1.049 | 1 |
| 24 | -10.3/h | 1 |
| 25 | -10.38 | 2 |
| 26 | -10.94 | 2 |
| 27 | -103.3 | 1 |
| 28 | -106.87 | 1 |
| 29 | -116.39 | 1 |
| 30 | -117.42 | 1 |
| 31 | -11‰ | 1 |
| 32 | -137.62 | 1 |
| 33 | -138.96 | 1 |
| 34 | -15.58 | 1 |
| 35 | -16.59 | 1 |
| 36 | -17.48 | 1 |
| 37 | -195.67 | 1 |
| 38 | -197.54 | 1 |
| 39 | -1·51 | 2 |
| 40 | -2.00+/-0.3 | 1 |
| 41 | -2.339 | 1 |
| 42 | -207.92 | 1 |
| 43 | -212.89 | 1 |
| 44 | -213 | 1 |
| 45 | -22.9±0.3°c | 1 |
| 46 | -224.7 | 1 |
| 47 | -257.69 | 1 |
| 48 | -25°c | 1 |
| 49 | -261.52 | 1 |
| 50 | -265.95 | 1 |
| 51 | -27.07 | 1 |
| 52 | -27.32 | 1 |
| 53 | -27.72 | 1 |
| 54 | -27.79 | 1 |
| 55 | -27.82 | 1 |
| 56 | -279.51 | 1 |
| 57 | -28.90 | 1 |
| 58 | -29.77 | 1 |
| 59 | -30.36 | 1 |
| 60 | -300.82 | 1 |
| 61 | -32.22 | 2 |
| 62 | -32.40 | 1 |
| 63 | -33.96 | 1 |
| 64 | -35.04 | 1 |
| 65 | -35.49 | 1 |
| 66 | -3f | 1 |
| 67 | -41.66 | 1 |
| 68 | -42.63 | 1 |
| 69 | -42.78 | 1 |
| 70 | -45.62 | 1 |
| 71 | -5.408 | 1 |
| 72 | -65.63 | 1 |
| 73 | -65.89 | 1 |
| 74 | -67.7±1.8mv | 1 |
| 75 | -702 | 1 |
| 76 | -78.13 | 1 |
| 77 | -78.90 | 1 |
| 78 | -8.14 | 1 |
| 79 | -8h | 1 |
| 80 | -9.07 | 1 |
| 81 | -97.47 | 1 |
| 82 | -adrenoblockers | 2 |
| 83 | -spadi- | 1 |
| 84 | -ssh | 1 |
| 85 | -£477 | 1 |
| 86 | 0-placebo | 1 |
| 87 | 0.000016 | 1 |
| 88 | 0.00229 | 1 |
| 89 | 0.00337 | 1 |
| 90 | 0.00399 | 1 |
| 91 | 0.01/min | 1 |
| 92 | 0.049mg/ml | 1 |
| 93 | 0.10+/-0.04 | 1 |
| 94 | 0.11db/nm | 1 |
| 95 | 0.12+/-0.07 | 1 |
| 96 | 0.1212 | 1 |
| 97 | 0.1455 | 1 |
| 98 | 0.15w/kg | 1 |
| 99 | 0.1770 | 1 |
| 100 | 0.20-1.00 | 2 |
| 101 | 0.2056 | 1 |
| 102 | 0.244μm | 1 |
| 103 | 0.2651 | 1 |
| 104 | 0.2nm | 1 |
| 105 | 0.3151 | 1 |
| 106 | 0.35°c | 3 |
| 107 | 0.36±0.05 | 1 |
| 108 | 0.39±0.22 | 1 |
| 109 | 0.40+/-0.11 | 1 |
| 110 | 0.40-0.50mg/kg/day | 1 |
| 111 | 0.42/patient | 1 |
| 112 | 0.44+/-0.10 | 1 |
| 113 | 0.5178 | 1 |
| 114 | 0.56+/-0.08 | 1 |
| 115 | 0.60±0.33 | 1 |
| 116 | 0.6logcfu/ml | 1 |
| 117 | 0.74-fold | 1 |
| 118 | 0.74/patient | 1 |
| 119 | 0.7653 | 2 |
| 120 | 0.81nmol/min/mg | 1 |
| 121 | 0.8304 | 1 |
| 122 | 0.86+/-0.04 | 1 |
| 123 | 0.8940 | 1 |
| 124 | 0.91±0.29 | 1 |
| 125 | 0.93±0.27μg/ml | 1 |
| 126 | 0.96.however | 1 |
| 127 | 0.9807 | 1 |
| 128 | 01/01/2014 | 1 |
| 129 | 01/11 | 1 |
| 130 | 02/11/94 | 1 |
| 131 | 03/31/2011 | 2 |
| 132 | 04/2010 | 1 |
| 133 | 05/2006 | 1 |
| 134 | 06/2001 | 1 |
| 135 | 07/2001 | 3 |
| 136 | 08/2010 | 1 |
| 137 | 08/2012 | 2 |
| 138 | 09-jan-2009 | 1 |
| 139 | 09/2001 | 1 |
| 140 | 1,08 | 1 |
| 141 | 1,110.12 | 1 |
| 142 | 1,265.03 | 1 |
| 143 | 1,382/100,000 | 1 |
| 144 | 1,4,16-pregnatriene-3,20-diones | 1 |
| 145 | 1-cyano-1,3-butadiene | 2 |
| 146 | 1-dodecanol | 2 |
| 147 | 1.00±0.52 | 1 |
| 148 | 1.0134 | 1 |
| 149 | 1.0848 | 1 |
| 150 | 1.1020 | 1 |
| 151 | 1.1208 | 1 |
| 152 | 1.17+/-0.23 | 3 |
| 153 | 1.2323 | 1 |
| 154 | 1.25µl/ml | 1 |
| 155 | 1.27±0.42 | 1 |
| 156 | 1.2±0.06 | 1 |
| 157 | 1.322 | 1 |
| 158 | 1.3441 | 1 |
| 159 | 1.35m | 1 |
| 160 | 1.388 | 1 |
| 161 | 1.44+/-0.44 | 1 |
| 162 | 1.538 | 2 |
| 163 | 1.54nmol/min/mg | 1 |
| 164 | 1.684 | 2 |
| 165 | 1.735 | 1 |
| 166 | 1.844 | 1 |
| 167 | 1.90±0.29 | 1 |
| 168 | 1.93-4.55 | 1 |
| 169 | 1.93±0.62 | 1 |
| 170 | 1.93±0.63 | 1 |
| 171 | 1.9410 | 1 |
| 172 | 1.94±0.34† | 1 |
| 173 | 1.9kg | 1 |
| 174 | 1/1,000,000 | 1 |
| 175 | 1/6/2009 | 1 |
| 176 | 1/800 | 2 |
| 177 | 1/radius | 1 |
| 178 | 10,809 | 1 |
| 179 | 10-30-2010 | 1 |
| 180 | 10-yearolds | 1 |
| 181 | 10.254 | 1 |
| 182 | 10.77kda | 1 |
| 183 | 10/12001 | 1 |
| 184 | 10/2001 | 1 |
| 185 | 10/2010 | 1 |
| 186 | 1000ng/ml | 3 |
| 187 | 100×10/l | 1 |
| 188 | 101.28 | 1 |
| 189 | 101.4°f | 1 |
| 190 | 101.57 | 1 |
| 191 | 101±26 | 1 |
| 192 | 107.24 | 1 |
| 193 | 10782 | 1 |
| 194 | 107±17 | 1 |
| 195 | 108.84 | 1 |
| 196 | 109°c | 1 |
| 197 | 11.5-4 | 1 |
| 198 | 11.981 | 1 |
| 199 | 11/19/93 | 1 |
| 200 | 1107.76μg/mlh | 1 |
| 201 | 112.4°c | 1 |
| 202 | 112.56 | 1 |
| 203 | 112°c | 1 |
| 204 | 114.70 | 1 |
| 205 | 1150°c | 1 |
| 206 | 1162+/-79mg | 1 |
| 207 | 117- | 1 |
| 208 | 117.24+/-27.21ms | 1 |
| 209 | 117.89 | 1 |
| 210 | 117.9±1.3 | 1 |
| 211 | 118.41+/-21.34ms | 1 |
| 212 | 11:00am | 2 |
| 213 | 11q21q23 | 1 |
| 214 | 11q22.3-q23 | 1 |
| 215 | 11μm | 1 |
| 216 | 12.2+/-4.0 | 1 |
| 217 | 12.3+/-4 | 1 |
| 218 | 12.407 | 1 |
| 219 | 12.5mg/ml | 1 |
| 220 | 12/15/2012 | 1 |
| 221 | 12/1999 | 1 |
| 222 | 12/22/09 | 1 |
| 223 | 12/31/2007 | 1 |
| 224 | 12/31/2009 | 1 |
| 225 | 12/31/2010 | 1 |
| 226 | 120/ml | 1 |
| 227 | 121.6±8.2 | 1 |
| 228 | 12300 | 1 |
| 229 | 125.79 | 1 |
| 230 | 1254.96 | 1 |
| 231 | 12º | 1 |
| 232 | 13,928 | 1 |
| 233 | 13.03°c | 1 |
| 234 | 13.48+/-1.79 | 1 |
| 235 | 13.824 | 1 |
| 236 | 13.8±13.1 | 1 |
| 237 | 132-h-olds | 1 |
| 238 | 134.14 | 1 |
| 239 | 13600 | 1 |
| 240 | 13years | 2 |
| 241 | 14.1±4 | 1 |
| 242 | 14.3±4.9 | 1 |
| 243 | 140,350 | 1 |
| 244 | 147/88 | 1 |
| 245 | 14t | 8 |
| 246 | 15,000/mm3 | 2 |
| 247 | 15-y-old | 2 |
| 248 | 15.64μm | 1 |
| 249 | 154° | 1 |
| 250 | 156.9/81.5 | 1 |
| 251 | 156°c | 1 |
| 252 | 157.15 | 1 |
| 253 | 15asb | 1 |
| 254 | 16.10€ | 1 |
| 255 | 16.83±4.73 | 1 |
| 256 | 167.85 | 1 |
| 257 | 1691µv | 1 |
| 258 | 16q21 | 1 |
| 259 | 17-year-olds | 17 |
| 260 | 17.004 | 1 |
| 261 | 17.5±2.6 | 1 |
| 262 | 17/ml | 1 |
| 263 | 170/100,000 | 1 |
| 264 | 172.11 | 1 |
| 265 | 175° | 1 |
| 266 | 179.29 | 1 |
| 267 | 17alpha-cyanomethyl-estradoil-3-methylether | 1 |
| 268 | 18-yr-olds | 1 |
| 269 | 18.0:1 | 1 |
| 270 | 18.17°c | 1 |
| 271 | 18.5±7.4 | 1 |
| 272 | 18.72±0.78μg/ml | 1 |
| 273 | 1833.69 | 1 |
| 274 | 18381+/-1772 | 1 |
| 275 | 187.74 | 1 |
| 276 | 189.27+/-28.49ms | 1 |
| 277 | 189.37 | 1 |
| 278 | 19-year-olds | 4 |
| 279 | 19.4±3.8 | 1 |
| 280 | 19.9±27.5ng/ml | 1 |
| 281 | 199.37 | 1 |
| 282 | 1:0.3 | 1 |
| 283 | 1:2569 | 1 |
| 284 | 1:90 | 1 |
| 285 | 1∶160 | 1 |
| 286 | 2'-amp/3'-amp | 1 |
| 287 | 2,3-dihydroazetes | 1 |
| 288 | 2,5-furandimethanol | 1 |
| 289 | 2,6-disubstitution | 1 |
| 290 | 2-acetolactate | 1 |
| 291 | 2-aryl-2,5-dihydro-1h-pyrroles | 1 |
| 292 | 2-methylpyrroline | 1 |
| 293 | 2.0035 | 1 |
| 294 | 2.05±0.29 | 1 |
| 295 | 2.0z | 1 |
| 296 | 2.1ppmv | 1 |
| 297 | 2.28mg/ml | 1 |
| 298 | 2.2±0.7 | 4 |
| 299 | 2.2±2.4mg/l | 1 |
| 300 | 2.30ng/l | 1 |
| 301 | 2.37±0.79 | 1 |
| 302 | 2.3±2.0pg/ml | 1 |
| 303 | 2.474 | 1 |
| 304 | 2.588 | 1 |
| 305 | 2.5±1.3 | 1 |
| 306 | 2.660 | 1 |
| 307 | 2.718 | 1 |
| 308 | 2.738 | 1 |
| 309 | 2.739 | 1 |
| 310 | 2.8±1.6 | 1 |
| 311 | 2.918 | 1 |
| 312 | 2/2010 | 1 |
| 313 | 20/2000 | 1 |
| 314 | 2000/02 | 1 |
| 315 | 2003-02 | 1 |
| 316 | 2005/12/31 | 1 |
| 317 | 2007/12/31 | 1 |
| 318 | 2010–2011 | 1 |
| 319 | 2013/06 | 1 |
| 320 | 2048µg/ml | 1 |
| 321 | 20ppm | 1 |
| 322 | 21,956 | 1 |
| 323 | 21.60+/-10.18 | 1 |
| 324 | 21.70+/-9.61 | 1 |
| 325 | 212.78 | 1 |
| 326 | 212.9 | 1 |
| 327 | 2120ml/min | 1 |
| 328 | 219,775 | 1 |
| 329 | 22.36µg/ml | 1 |
| 330 | 222.054 | 1 |
| 331 | 2245°c | 1 |
| 332 | 225±137pg/ml | 1 |
| 333 | 22nm | 1 |
| 334 | 23,679 | 1 |
| 335 | 231.0+/-3.2mg/dl | 1 |
| 336 | 231.51 | 1 |
| 337 | 231.84 | 1 |
| 338 | 239.68 | 2 |
| 339 | 23±1 | 1 |
| 340 | 24-years-old | 1 |
| 341 | 24.38 | 2 |
| 342 | 2400nm | 1 |
| 343 | 245,724 | 1 |
| 344 | 245°c | 1 |
| 345 | 247° | 1 |
| 346 | 24:58 | 1 |
| 347 | 24:5n-3 | 6 |
| 348 | 24years | 1 |
| 349 | 25.140 | 1 |
| 350 | 25.94μm | 1 |
| 351 | 250,286 | 1 |
| 352 | 2510.0 | 1 |
| 353 | 2559.2 | 1 |
| 354 | 26,439euro/qaly | 1 |
| 355 | 26.8±4 | 1 |
| 356 | 260.49 | 1 |
| 357 | 262,567 | 1 |
| 358 | 263°c | 1 |
| 359 | 27/11/09 | 1 |
| 360 | 278±14nmol/l | 1 |
| 361 | 27mev | 1 |
| 362 | 28.46±8.24nmol/μg/h | 1 |
| 363 | 280mg/dl | 1 |
| 364 | 2895.53mg | 1 |
| 365 | 28nm | 1 |
| 366 | 29.1+/-1.4 | 1 |
| 367 | 29.7delta | 1 |
| 368 | 290bp | 1 |
| 369 | 291.82 | 1 |
| 370 | 296.4 | 1 |
| 371 | 29±1 | 4 |
| 372 | 2gy×30 | 1 |
| 373 | 3,067 | 1 |
| 374 | 3,4,3',4'-tetrahydrospirilloxanthin | 1 |
| 375 | 3,4-dihydrocoumarins | 1 |
| 376 | 3-day-plaque-regrowth-interval | 1 |
| 377 | 3-pyridylnitrenes | 2 |
| 378 | 3-xorsat | 1 |
| 379 | 3.345 | 1 |
| 380 | 3.36°c | 1 |
| 381 | 3.37±0.9 | 1 |
| 382 | 3.464 | 1 |
| 383 | 3.485 | 1 |
| 384 | 3.53-fold | 1 |
| 385 | 3.5nm | 1 |
| 386 | 3.5μg/day | 1 |
| 387 | 3.6±1.0 | 1 |
| 388 | 3.772 | 1 |
| 389 | 3.7±1.8 | 1 |
| 390 | 3.816 | 1 |
| 391 | 3/fistula | 1 |
| 392 | 30.12.2011 | 1 |
| 393 | 30/08/2012 | 1 |
| 394 | 30/october/2013 | 1 |
| 395 | 300kgy | 1 |
| 396 | 301.08 | 1 |
| 397 | 302±15nmol/l | 1 |
| 398 | 30±6kg/m2 | 1 |
| 399 | 31+/-18 | 1 |
| 400 | 31-12-94 | 1 |
| 401 | 31.3+/-3.1 | 1 |
| 402 | 31.3±6.8 | 1 |
| 403 | 31/10/2001 | 1 |
| 404 | 31/7/2007 | 1 |
| 405 | 310k | 1 |
| 406 | 31±1.8ms | 1 |
| 407 | 32.2ml | 1 |
| 408 | 327±88u.carr | 1 |
| 409 | 33.3±2.89 | 1 |
| 410 | 337.785±84.504 | 1 |
| 411 | 34.713 | 1 |
| 412 | 3420bp | 1 |
| 413 | 343.9 | 1 |
| 414 | 35-29°c | 1 |
| 415 | 350ms | 1 |
| 416 | 37/hr | 1 |
| 417 | 3700m | 1 |
| 418 | 38,921€ | 1 |
| 419 | 38.3℃ | 1 |
| 420 | 38.5μm | 1 |
| 421 | 38.7dgc | 1 |
| 422 | 383.97 | 1 |
| 423 | 386.6 | 1 |
| 424 | 393.66 | 1 |
| 425 | 3tc/ftc | 2 |
| 426 | 3β-acetoxy-16-methylene-androst-5-en-17-one | 1 |
| 427 | 4-6-month-old | 1 |
| 428 | 4-8/4-16 | 1 |
| 429 | 4-hydroxy-2-ketobutyrate | 2 |
| 430 | 4-hydroxyphenylglyoxylate | 1 |
| 431 | 4-methylvalerate | 1 |
| 432 | 4.0/1.9 | 1 |
| 433 | 4.007 | 1 |
| 434 | 4.112 | 1 |
| 435 | 4.4+/-0.7 | 1 |
| 436 | 4.5-6g | 1 |
| 437 | 4.58°c | 1 |
| 438 | 4.5mmhg | 1 |
| 439 | 4/30/2010 | 1 |
| 440 | 40-60g | 1 |
| 441 | 4000mg/l | 1 |
| 442 | 403.99 | 1 |
| 443 | 405/100,000 | 1 |
| 444 | 409.3 | 1 |
| 445 | 40g/day | 3 |
| 446 | 40k/min | 1 |
| 447 | 40°c/exh | 1 |
| 448 | 40°s | 1 |
| 449 | 41,7ºc | 1 |
| 450 | 41.75 | 2 |
| 451 | 414-fold | 1 |
| 452 | 43.0°c | 2 |
| 453 | 43.3+/-3.4 | 1 |
| 454 | 43.3±29.1 | 1 |
| 455 | 44-year-olds | 4 |
| 456 | 44.7°±12.3° | 1 |
| 457 | 44/80 | 1 |
| 458 | 4479 | 1 |
| 459 | 45.1+/-9.7 | 1 |
| 460 | 45.4±0.9 | 1 |
| 461 | 46+/-18 | 1 |
| 462 | 46.0fg | 1 |
| 463 | 46.80€ | 1 |
| 464 | 47,600ppm | 1 |
| 465 | 48-years-old | 1 |
| 466 | 48.0pg/ml | 1 |
| 467 | 49.4±21.0µmol/l | 1 |
| 468 | 4·04 | 1 |
| 469 | 5-fu/rt | 1 |
| 470 | 5.0/20 | 1 |
| 471 | 5.00°c | 1 |
| 472 | 5.1/100py | 1 |
| 473 | 5.14+/-2 | 1 |
| 474 | 5.1997 | 1 |
| 475 | 5.1:1 | 1 |
| 476 | 5.21°c | 1 |
| 477 | 5.2°c | 1 |
| 478 | 5.34-fold | 1 |
| 479 | 5.354 | 1 |
| 480 | 5.36+/-0.61 | 1 |
| 481 | 5.3702 | 1 |
| 482 | 5.446 | 1 |
| 483 | 5.5±4.9ng/ml | 1 |
| 484 | 5.7× | 1 |
| 485 | 5.858 | 1 |
| 486 | 5.935 | 1 |
| 487 | 5000.00ng/ml | 1 |
| 488 | 50min | 4 |
| 489 | 53.1°c | 1 |
| 490 | 5355±1257/µl | 1 |
| 491 | 537.52 | 1 |
| 492 | 54-year-olds | 3 |
| 493 | 55.68 | 1 |
| 494 | 55.72 | 1 |
| 495 | 55/hr | 1 |
| 496 | 55nm | 1 |
| 497 | 56.5/100,000 | 1 |
| 498 | 560°c | 1 |
| 499 | 56h | 1 |
| 500 | 56±35 | 1 |
| 501 | 57,460 | 1 |
| 502 | 57.6±4.1 | 1 |
| 503 | 575k | 1 |
| 504 | 58.2/100,000/year | 1 |
| 505 | 58.4g/l | 1 |
| 506 | 58.9-fold | 1 |
| 507 | 59-year-olds | 2 |
| 508 | 59.5°c | 1 |
| 509 | 5=difficult | 1 |
| 510 | 5x10-4 | 1 |
| 511 | 5°c/h | 1 |
| 512 | 5α-androstanedione-3,17-dione | 1 |
| 513 | 6-oxygen | 1 |
| 514 | 6.00/1000 | 1 |
| 515 | 6.0±3.1 | 1 |
| 516 | 6.684 | 1 |
| 517 | 6.94±4.02 | 1 |
| 518 | 6/2012 | 1 |
| 519 | 60.39 | 1 |
| 520 | 600μm | 4 |
| 521 | 60days | 7 |
| 522 | 61.10 | 1 |
| 523 | 64-year-olds | 3 |
| 524 | 64.6±23.6 | 1 |
| 525 | 65.4ppmv | 1 |
| 526 | 65.935 | 1 |
| 527 | 675.5 | 1 |
| 528 | 676nm | 1 |
| 529 | 68.95 | 1 |
| 530 | 69-year-olds | 3 |
| 531 | 694.1 | 1 |
| 532 | 6m/s | 1 |
| 533 | 7,253€ | 1 |
| 534 | 7.215 | 1 |
| 535 | 7.6+/-2.8 | 1 |
| 536 | 7.789 | 1 |
| 537 | 7.7nm | 1 |
| 538 | 7.97+/-0.85 | 1 |
| 539 | 7.9±2.8 | 1 |
| 540 | 7/1/2013 | 1 |
| 541 | 706.74 | 1 |
| 542 | 71.20 | 1 |
| 543 | 71.3m | 1 |
| 544 | 71.570±4.324μg/ml | 1 |
| 545 | 71.72°c | 1 |
| 546 | 72min | 1 |
| 547 | 72±8beats/min | 1 |
| 548 | 73.8±23.3µmol/l | 1 |
| 549 | 75,500/µl | 1 |
| 550 | 76.50 | 1 |
| 551 | 77.26 | 1 |
| 552 | 78+/-8mmhg | 1 |
| 553 | 78.02 | 1 |
| 554 | 78°c≈tm | 1 |
| 555 | 794aa | 1 |
| 556 | 7mer | 1 |
| 557 | 7·09 | 1 |
| 558 | 8-10cmh2o | 1 |
| 559 | 8-nitroguanosine | 1 |
| 560 | 8.2/10 | 1 |
| 561 | 8.334 | 1 |
| 562 | 8.5×1011b | 1 |
| 563 | 8.67±2.13 | 1 |
| 564 | 8.7/micromol/l | 1 |
| 565 | 8.741 | 1 |
| 566 | 8.7±2.5 | 1 |
| 567 | 80.22 | 1 |
| 568 | 80µg/day | 1 |
| 569 | 81- | 1 |
| 570 | 8167±3111 | 1 |
| 571 | 83.17 | 2 |
| 572 | 84.4kg | 1 |
| 573 | 85.6.8+/-7.6mg | 1 |
| 574 | 8512 | 1 |
| 575 | 86.35µg/ml | 1 |
| 576 | 869,250 | 1 |
| 577 | 88.70 | 1 |
| 578 | 886.3 | 1 |
| 579 | 9-oh-add | 1 |
| 580 | 9.0m | 1 |
| 581 | 9.73μm | 1 |
| 582 | 9.therefore | 1 |
| 583 | 9/30/12 | 1 |
| 584 | 9/h | 1 |
| 585 | 90+°c | 1 |
| 586 | 90.96 | 1 |
| 587 | 92.0±40.5mmol/l | 1 |
| 588 | 93.1°c | 1 |
| 589 | 93.6°c | 1 |
| 590 | 94.0°c | 1 |
| 591 | 95.5º | 1 |
| 592 | 9596±3907 | 1 |
| 593 | 96hour | 1 |
| 594 | 97kw | 1 |
| 595 | 98.5±28.1 | 1 |
| 596 | 99.3±15.1μmol/min/ml | 1 |
| 597 | a.oryzoe | 1 |
| 598 | a.r | 1 |
| 599 | a/duck/quangngai/1037/2011 | 1 |
| 600 | a=135 | 1 |
| 601 | aa-subjects | 1 |
| 602 | acclimatisation/adaptation | 1 |
| 603 | accurate-reporting | 2 |
| 604 | acetopyruvate | 1 |
| 605 | acetycholine | 1 |
| 606 | achsp70 | 1 |
| 607 | acidiphilic | 1 |
| 608 | acra8 | 1 |
| 609 | ad/dementia | 5 |
| 610 | adaptation/habituation | 1 |
| 611 | ademe-thionine | 1 |
| 612 | adenotonsilectomy | 1 |
| 613 | adiabaticity | 2 |
| 614 | administer.thus | 1 |
| 615 | adoprazine | 1 |
| 616 | adults.moreover | 1 |
| 617 | aerofluxus | 1 |
| 618 | aflp4 | 1 |
| 619 | al-hada | 1 |
| 620 | aldophosphamide | 1 |
| 621 | alkoxypropanols | 1 |
| 622 | alprazolam-exposure | 1 |
| 623 | alr-5iia-1-1 | 1 |
| 624 | amdo | 1 |
| 625 | amino-penicillins | 4 |
| 626 | aminodinitrotoluenes | 1 |
| 627 | amoxicillin-clavunanic | 1 |
| 628 | anareolineales | 1 |
| 629 | ang-i | 1 |
| 630 | angiographic-guided | 1 |
| 631 | angiomyxomas | 2 |
| 632 | annelida-dominated | 1 |
| 633 | anoxia-reoxygenation | 2 |
| 634 | antero-septum | 1 |
| 635 | anthropopressure | 1 |
| 636 | antibioterrorism | 1 |
| 637 | antibiotics/chemotherapeutics | 2 |
| 638 | ap24567 | 3 |
| 639 | application-oriented | 1 |
| 640 | aquarists | 1 |
| 641 | arabinosylthymine | 2 |
| 642 | arg346 | 1 |
| 643 | argonaute-2 | 1 |
| 644 | asthenoteratospermia | 1 |
| 645 | asthmagens | 1 |
| 646 | atenolol/bendroflumethiazide | 1 |
| 647 | attempts-much | 1 |
| 648 | attention/default-mode | 1 |
| 649 | at→cmf | 1 |
| 650 | autoinfection | 1 |
| 651 | avgtmean | 2 |
| 652 | azepanium | 1 |
| 653 | azt-backbones | 1 |
| 654 | b-albumin | 1 |
| 655 | barc-3b | 1 |
| 656 | baseline/mp | 1 |
| 657 | bde-154 | 2 |
| 658 | belch | 17 |
| 659 | betalactams | 8 |
| 660 | bhubaneswar | 1 |
| 661 | bias.meta-analyses | 2 |
| 662 | bilharzias | 2 |
| 663 | biodiesels-wsf | 1 |
| 664 | biopersistence | 2 |
| 665 | bleeding/pain | 11 |
| 666 | blumberger | 1 |
| 667 | bottlefeeding | 1 |
| 668 | bpda | 4 |
| 669 | brickworks | 1 |
| 670 | brining | 2 |
| 671 | bronchoconstrict | 1 |
| 672 | bronchosecretolytics | 1 |
| 673 | bu+clo+flu | 3 |
| 674 | bu+clo+flu+sor | 5 |
| 675 | c-cbl | 1 |
| 676 | c52 | 1 |
| 677 | c57black6 | 1 |
| 678 | c6s | 1 |
| 679 | calbicans | 1 |
| 680 | calculed | 1 |
| 681 | cancerous-tissues | 1 |
| 682 | carbapenemics | 1 |
| 683 | cardiocentre | 1 |
| 684 | cardiomyoctyes | 1 |
| 685 | carvedilol.6 | 1 |
| 686 | cav3-wt | 3 |
| 687 | cdai/sdai | 1 |
| 688 | cefoxitine | 2 |
| 689 | cellularize | 1 |
| 690 | cephotaxim | 2 |
| 691 | cephtizoxin | 1 |
| 692 | cerebrovasculopathy | 1 |
| 693 | cervugid-ovules | 1 |
| 694 | cgp37157 | 1 |
| 695 | ch2fcd2cl | 2 |
| 696 | chaetonotida | 1 |
| 697 | chemoimmobilisation | 1 |
| 698 | chlormphenicol | 1 |
| 699 | chondroitin-4-sulphate | 1 |
| 700 | chr-1 | 1 |
| 701 | cineangiocoronarography | 1 |
| 702 | ciproflaxacine | 1 |
| 703 | cirrhosis-hcc | 1 |
| 704 | cis-3-hexene | 3 |
| 705 | cisplatinum-5-fluoro-uracile | 1 |
| 706 | citrus-like | 1 |
| 707 | ckd-4 | 3 |
| 708 | clandes-tine | 1 |
| 709 | clavate | 1 |
| 710 | cldn-1- | 1 |
| 711 | clear-white | 1 |
| 712 | clidox-s | 2 |
| 713 | cmt1 | 1 |
| 714 | cntln | 2 |
| 715 | co-classify | 1 |
| 716 | co-create | 1 |
| 717 | colerin | 1 |
| 718 | colisepticaemia | 1 |
| 719 | commonness | 2 |
| 720 | condensed-phase | 2 |
| 721 | conditioned-cues | 1 |
| 722 | confess | 9 |
| 723 | control-hdl | 1 |
| 724 | control/waiting-list | 1 |
| 725 | corticoid-therapy | 1 |
| 726 | counsellee | 2 |
| 727 | cowardice | 1 |
| 728 | cpap.new | 1 |
| 729 | cpl1/fiery2 | 1 |
| 730 | craig-walker | 1 |
| 731 | cris-153 | 1 |
| 732 | cs-tdcs | 4 |
| 733 | ctx-injection | 1 |
| 734 | culture-result | 1 |
| 735 | cuproenzymes | 1 |
| 736 | cuteness | 1 |
| 737 | cys-orthologues | 1 |
| 738 | cys191 | 1 |
| 739 | c₆₄ | 1 |
| 740 | d-glcp | 1 |
| 741 | d-penicillamine-like | 1 |
| 742 | d0/1-dissection | 1 |
| 743 | d14-3-3ε | 1 |
| 744 | d2cc | 1 |
| 745 | d365 | 1 |
| 746 | date | 7,450 |
| 747 | dates | 396 |
| 748 | dauricum | 2 |
| 749 | day14 | 1 |
| 750 | decannulate | 2 |
| 751 | december-2010 | 1 |
| 752 | december-2011 | 1 |
| 753 | december/2009 | 1 |
| 754 | december/94 | 1 |
| 755 | december，1995 | 1 |
| 756 | declassified | 2 |
| 757 | defervesce | 5 |
| 758 | defragmented | 1 |
| 759 | deliquesce | 1 |
| 760 | delivery.results | 1 |
| 761 | dexamethasone.there | 1 |
| 762 | diabetes.acarbose | 1 |
| 763 | dihydroergotamine/metoclopramide | 2 |
| 764 | dihydroquinones | 1 |
| 765 | dimethylacrylamide | 1 |
| 766 | disc/fovea | 1 |
| 767 | diverticuli | 2 |
| 768 | drb3- | 1 |
| 769 | dtdp-3-keto-6-deoxyglucose | 1 |
| 770 | dyserythopoiesis | 1 |
| 771 | e2-3,4-quinone | 1 |
| 772 | eachketena | 1 |
| 773 | ecasa+c | 1 |
| 774 | eclose | 1 |
| 775 | eds-analysis | 1 |
| 776 | efmtool | 1 |
| 777 | eight-hours | 3 |
| 778 | en/iso | 1 |
| 779 | end-r | 3 |
| 780 | endolysins | 1 |
| 781 | endomondo.com | 1 |
| 782 | endovasculature | 1 |
| 783 | endoxylanases | 3 |
| 784 | enets-tnm | 1 |
| 785 | eotp | 3 |
| 786 | epimerize | 1 |
| 787 | episclera | 2 |
| 788 | er-a | 1 |
| 789 | er/pr+tumors | 1 |
| 790 | ergosteryl-3β-glucoside | 1 |
| 791 | erlotinib/hcq | 1 |
| 792 | erucin | 4 |
| 793 | ethephon | 4 |
| 794 | euro122 | 1 |
| 795 | euro28,000 | 1 |
| 796 | euthanization | 5 |
| 797 | events-angiographic | 1 |
| 798 | exemptors | 1 |
| 799 | exercise+hsgs | 2 |
| 800 | extensiometry | 1 |
| 801 | extubate | 28 |
| 802 | fac6 | 1 |
| 803 | face-to-face-programming | 1 |
| 804 | face/telephone | 1 |
| 805 | falsifications | 2 |
| 806 | fansler-arnold | 1 |
| 807 | fatigue/nausea | 1 |
| 808 | fe2+-heme | 1 |
| 809 | fecosterol | 1 |
| 810 | fefdbi | 1 |
| 811 | fhb-resistance | 1 |
| 812 | fhcd59-1.7 | 1 |
| 813 | fimbriectomy | 2 |
| 814 | finnger | 1 |
| 815 | flatus/feces | 1 |
| 816 | fluorimeters | 1 |
| 817 | fluoxetine-only | 4 |
| 818 | follow-up.overall | 1 |
| 819 | follow-up/withdrawals | 1 |
| 820 | fourtheme | 2 |
| 821 | fra3b | 1 |
| 822 | friday | 75 |
| 823 | fruition | 7 |
| 824 | fty-bl | 4 |
| 825 | gal-8 | 2 |
| 826 | gatifloxacine | 1 |
| 827 | gaze-assistance | 1 |
| 828 | gb16889-2008 | 1 |
| 829 | glit | 2 |
| 830 | gonzales-crussi | 1 |
| 831 | grayanotoxins | 2 |
| 832 | gsg | 3 |
| 833 | h.n | 1 |
| 834 | h266 | 1 |
| 835 | haemos | 1 |
| 836 | haems | 3 |
| 837 | hanatoxin | 1 |
| 838 | handihaler™ | 1 |
| 839 | hb-21 | 1 |
| 840 | hb-koln | 1 |
| 841 | hbv-genotypes | 2 |
| 842 | hcv/treatment | 1 |
| 843 | heart-failure-patients | 1 |
| 844 | heat.2 | 1 |
| 845 | helmintiasis | 1 |
| 846 | hemadsorb | 1 |
| 847 | hepta-bdes | 1 |
| 848 | hexacoordination | 1 |
| 849 | hfd+placebo | 1 |
| 850 | hfd-control | 1 |
| 851 | hgd/adenocarcinoma | 1 |
| 852 | hgkrp | 1 |
| 853 | hierarchist | 1 |
| 854 | high-expected-benefit | 1 |
| 855 | high/normal | 1 |
| 856 | hiv-1-rt | 1 |
| 857 | hiv-serostatus | 3 |
| 858 | hivp24 | 1 |
| 859 | hodja | 2 |
| 860 | homodimerize | 1 |
| 861 | housekeep | 1 |
| 862 | hph1 | 1 |
| 863 | hpv-6/11 | 2 |
| 864 | hsp110-like | 1 |
| 865 | htg6 | 1 |
| 866 | hunt-lawrence-rodino | 1 |
| 867 | hypertension/dyslipidaemia | 1 |
| 868 | hypo-vitaminosis | 1 |
| 869 | hypoxia-re-oxygenation | 1 |
| 870 | iasi | 8 |
| 871 | ie2 | 1 |
| 872 | ifn-α-stimulation | 1 |
| 873 | ifnalpha-2b | 1 |
| 874 | ifosfamide/heat | 1 |
| 875 | ih-c₆₀ | 1 |
| 876 | ii-ii | 1 |
| 877 | imipenum | 1 |
| 878 | immunity/defence | 1 |
| 879 | immuno-incompetence | 2 |
| 880 | incinerate | 1 |
| 881 | indisulam | 2 |
| 882 | injection-aspiration | 1 |
| 883 | injury/reperfusion | 3 |
| 884 | internet/blogs | 1 |
| 885 | introspect | 2 |
| 886 | iodine-deficiency | 1 |
| 887 | iso-amyl-cyanoacrylate | 1 |
| 888 | isolg-ethanolamine | 1 |
| 889 | isoviscous | 1 |
| 890 | itrazonazole | 1 |
| 891 | ivbor | 1 |
| 892 | january1 | 1 |
| 893 | jiejian | 1 |
| 894 | june2014 | 1 |
| 895 | just/us | 2 |
| 896 | jírovec | 1 |
| 897 | k.b.a | 1 |
| 898 | k.n. | 1 |
| 899 | kadir | 1 |
| 900 | ken-a | 1 |
| 901 | krimmer | 1 |
| 902 | l-halotryptophans | 1 |
| 903 | l10f | 1 |
| 904 | lack-of-efficacy | 1 |
| 905 | landlines | 7 |
| 906 | late-1990s | 1 |
| 907 | leonhard | 1 |
| 908 | levcromakalim | 1 |
| 909 | level-walking | 1 |
| 910 | lhex | 2 |
| 911 | li-diffusion | 1 |
| 912 | libaf3 | 1 |
| 913 | liberase-hi | 1 |
| 914 | lights-off | 1 |
| 915 | lignocellulases | 1 |
| 916 | lithium/valproate/carbamazepine | 1 |
| 917 | loc_os06g226100 | 1 |
| 918 | locally-generated | 1 |
| 919 | loe-5 | 1 |
| 920 | lp1-ibdv | 2 |
| 921 | lt-i | 6 |
| 922 | lynchpins | 1 |
| 923 | lysosomes/autolysosomes | 1 |
| 924 | m173 | 1 |
| 925 | m=1.27 | 1 |
| 926 | mace+ | 3 |
| 927 | macrodasyida | 1 |
| 928 | mainframes | 1 |
| 929 | mandibulata | 1 |
| 930 | mandya | 1 |
| 931 | mar.2013 | 1 |
| 932 | marañón | 5 |
| 933 | march-2013 | 1 |
| 934 | march/97 | 1 |
| 935 | marcus.currently | 1 |
| 936 | martentoxin | 1 |
| 937 | mastreviruses | 1 |
| 938 | mdct/mr | 1 |
| 939 | me/pathophysiology | 1 |
| 940 | mean≥3.00 | 2 |
| 941 | medicus/medline | 3 |
| 942 | metamyelocytes | 1 |
| 943 | methanediazohydroxide | 1 |
| 944 | methylxantines | 2 |
| 945 | metula | 1 |
| 946 | metylphenidate | 1 |
| 947 | mevalonate-3-phosphate | 1 |
| 948 | mex3c | 1 |
| 949 | mf-mpi | 1 |
| 950 | mfs/cess | 2 |
| 951 | microatheromas | 2 |
| 952 | micron-sizes | 1 |
| 953 | microphlypnus | 1 |
| 954 | microspherocytes | 1 |
| 955 | midtest | 6 |
| 956 | mild/none | 1 |
| 957 | mini-hlm-revascularisation | 1 |
| 958 | misjudgment | 1 |
| 959 | mists | 4 |
| 960 | mitxantrone | 1 |
| 961 | mn-gtp | 1 |
| 962 | monochromatization | 1 |
| 963 | mopotsyo | 1 |
| 964 | mrt2* | 1 |
| 965 | mtz-plac | 2 |
| 966 | mucosecretion | 1 |
| 967 | multi-peaks | 1 |
| 968 | multidrugs | 1 |
| 969 | mvbs/lysosomes | 1 |
| 970 | myalgia-myopathy | 1 |
| 971 | myocardiacyte | 1 |
| 972 | mzimba | 1 |
| 973 | n-sulfonylaziridines | 1 |
| 974 | na-processing | 1 |
| 975 | nazzi | 1 |
| 976 | ne/erp-variability | 1 |
| 977 | nestmates | 1 |
| 978 | neutral/menthol | 1 |
| 979 | never-drinkers | 1 |
| 980 | ni/w/sba-15 | 1 |
| 981 | nicu/hospital | 1 |
| 982 | nitrofuraintoin | 1 |
| 983 | no-tvt | 1 |
| 984 | no-ufh | 1 |
| 985 | non-anticipation | 1 |
| 986 | non-avoidance | 1 |
| 987 | non-chemists | 1 |
| 988 | non-crossovers | 1 |
| 989 | non-doctors | 2 |
| 990 | non-employment | 2 |
| 991 | non-oestrogen-treated | 1 |
| 992 | non-persistency | 1 |
| 993 | non-pharmacodynamic | 1 |
| 994 | non-suicides | 1 |
| 995 | non-thermophiles | 1 |
| 996 | non-warmed | 1 |
| 997 | nonamputees | 1 |
| 998 | nonsubjects | 1 |
| 999 | nonteratogens | 1 |
| 1000 | normal.3 | 1 |
| 1001 | nprup3 | 1 |
| 1002 | ntng | 1 |
| 1003 | nursing-homes | 2 |
| 1004 | nylen | 1 |
| 1005 | nε-hcy-proteins | 1 |
| 1006 | n∼45,000 | 1 |
| 1007 | ohv | 4 |
| 1008 | okt3/atg | 1 |
| 1009 | oligoamucorrhea | 1 |
| 1010 | olinda|exm | 2 |
| 1011 | ophiocara | 1 |
| 1012 | osmoregulate | 1 |
| 1013 | ovalocytosis | 1 |
| 1014 | over-harvesting | 2 |
| 1015 | overcollecting | 1 |
| 1016 | overconsume | 1 |
| 1017 | overdrink | 1 |
| 1018 | oxalyl-coa | 1 |
| 1019 | p38-blockade | 1 |
| 1020 | p495-mutations | 1 |
| 1021 | packers | 1 |
| 1022 | paired-tms | 1 |
| 1023 | pakg | 1 |
| 1024 | pam-nt3 | 1 |
| 1025 | paracrine-driven | 1 |
| 1026 | paraphymosis | 1 |
| 1027 | partington-rochelle | 1 |
| 1028 | passeriforms | 1 |
| 1029 | passover | 2 |
| 1030 | patients'or | 1 |
| 1031 | patients'sex | 1 |
| 1032 | pcos-controls | 1 |
| 1033 | pentanethiol | 1 |
| 1034 | pep-speech | 1 |
| 1035 | pgy-6 | 1 |
| 1036 | pharmaco-economics | 4 |
| 1037 | phocomelia | 1 |
| 1038 | phonate | 1 |
| 1039 | phosphatidylinositol-3,4,5-triphosphate | 2 |
| 1040 | phospho-s1444 | 2 |
| 1041 | photo-sensibilization | 1 |
| 1042 | photonlike | 1 |
| 1043 | pinch/pressure | 1 |
| 1044 | pio+lacebo | 1 |
| 1045 | plabebo | 1 |
| 1046 | placebo.finally | 1 |
| 1047 | placebo.however | 1 |
| 1048 | placebo/dextran | 1 |
| 1049 | play/study | 1 |
| 1050 | pleurocapsales | 1 |
| 1051 | plus-crossing | 1 |
| 1052 | pml-multimerization | 1 |
| 1053 | pn-n-1307:1994 | 1 |
| 1054 | pn7 | 2 |
| 1055 | pnd-21 | 1 |
| 1056 | pnd8 | 1 |
| 1057 | pod14 | 1 |
| 1058 | poeticness | 1 |
| 1059 | pollinate | 1 |
| 1060 | population/setting | 1 |
| 1061 | post-fbt | 1 |
| 1062 | post-think-aloud | 1 |
| 1063 | postdifferences | 1 |
| 1064 | pound154,752 | 1 |
| 1065 | pound400 | 1 |
| 1066 | ppatg18 | 1 |
| 1067 | pre-ect | 1 |
| 1068 | pre-ekgs | 1 |
| 1069 | pre-flow | 1 |
| 1070 | pre-rvd | 1 |
| 1071 | prerace-performance | 1 |
| 1072 | pretensioning | 5 |
| 1073 | pretzel-baking | 1 |
| 1074 | pro35s | 1 |
| 1075 | procline | 1 |
| 1076 | procreate | 5 |
| 1077 | pseudopulicidae | 1 |
| 1078 | ptca/stenting | 1 |
| 1079 | pyrazolidines | 1 |
| 1080 | pyrearinus | 1 |
| 1081 | pyrenochaeta | 1 |
| 1082 | qsy21 | 1 |
| 1083 | quadrupeds | 1 |
| 1084 | question-answering | 1 |
| 1085 | quinone- | 1 |
| 1086 | r-chop-ie | 1 |
| 1087 | radiosterilization | 2 |
| 1088 | ratrav | 3 |
| 1089 | rbc-c-a | 2 |
| 1090 | rbc-membranes | 1 |
| 1091 | re-anesthetise | 1 |
| 1092 | re-dose | 3 |
| 1093 | re-epithelialize | 3 |
| 1094 | re-operating | 1 |
| 1095 | real-timely | 1 |
| 1096 | rectitis | 1 |
| 1097 | rehberg-tareev | 1 |
| 1098 | rejection/acceptance | 1 |
| 1099 | reoperate | 1 |
| 1100 | resend | 1 |
| 1101 | response/tolerability | 1 |
| 1102 | rex-group | 2 |
| 1103 | rh0808 | 1 |
| 1104 | rips | 2 |
| 1105 | rs16861210 | 1 |
| 1106 | récurettage | 1 |
| 1107 | s-lps | 4 |
| 1108 | s/plc | 1 |
| 1109 | score≤60 | 1 |
| 1110 | sds-electrophoresis | 1 |
| 1111 | se-asia | 1 |
| 1112 | sedoheptulose-7-phosphate | 1 |
| 1113 | self-agglutination | 1 |
| 1114 | self-catheterize | 2 |
| 1115 | self-needlers | 1 |
| 1116 | self-protect | 5 |
| 1117 | self-react | 1 |
| 1118 | self-reflect | 1 |
| 1119 | self-reproduction | 1 |
| 1120 | self-vaccinate | 1 |
| 1121 | semi-reflectors | 1 |
| 1122 | semiprofile | 1 |
| 1123 | seomulyuchan | 2 |
| 1124 | ser404 | 1 |
| 1125 | ser49/ser49 | 1 |
| 1126 | sham-pap | 2 |
| 1127 | sharmanism | 1 |
| 1128 | shellfishing | 1 |
| 1129 | shelter-providing | 1 |
| 1130 | shoals | 3 |
| 1131 | shoplift | 3 |
| 1132 | sialilation | 1 |
| 1133 | situations/problems | 1 |
| 1134 | sleeep | 1 |
| 1135 | sligrl | 2 |
| 1136 | slt5 | 3 |
| 1137 | smartsteps-only | 2 |
| 1138 | sn38 | 2 |
| 1139 | society-low | 1 |
| 1140 | soothe/comfort | 1 |
| 1141 | sphincterolysis | 2 |
| 1142 | spmab | 1 |
| 1143 | sr2ruo4 | 1 |
| 1144 | srascov | 1 |
| 1145 | ss-lactams | 1 |
| 1146 | sse1p | 1 |
| 1147 | st-101 | 1 |
| 1148 | st85 | 1 |
| 1149 | staggered-onset | 1 |
| 1150 | stagnate | 1 |
| 1151 | steadman | 1 |
| 1152 | steradiene | 1 |
| 1153 | subspecialize | 1 |
| 1154 | sulfamethoxazole/trimetoprim | 1 |
| 1155 | super-shedders | 1 |
| 1156 | supra-infections | 1 |
| 1157 | swelling/hydrops | 1 |
| 1158 | systematists | 1 |
| 1159 | t-13 | 1 |
| 1160 | t-family | 1 |
| 1161 | tambacunda | 1 |
| 1162 | target-screen | 1 |
| 1163 | tc+tse | 1 |
| 1164 | tcm/acupuncture | 1 |
| 1165 | tcs2 | 2 |
| 1166 | tcu-pa | 3 |
| 1167 | tcu380 | 2 |
| 1168 | teleosemantics | 1 |
| 1169 | tension/stress | 1 |
| 1170 | test-temperatures | 3 |
| 1171 | tethracycline | 1 |
| 1172 | tetracylines | 1 |
| 1173 | tezampanel | 1 |
| 1174 | tfeis | 1 |
| 1175 | therapeutic-modalities | 1 |
| 1176 | thiolates | 3 |
| 1177 | thioles | 1 |
| 1178 | tiamphenicol | 1 |
| 1179 | time-off-work | 1 |
| 1180 | time-to-time | 1 |
| 1181 | tinyurl.com/pggfrwn | 1 |
| 1182 | tocolyticum | 1 |
| 1183 | tom70 | 1 |
| 1184 | toxin-degradation | 1 |
| 1185 | tpr/fpr | 1 |
| 1186 | traditional-only | 4 |
| 1187 | trans-autophosphorylation | 2 |
| 1188 | transdisciplinarity | 1 |
| 1189 | treadmill-tests | 1 |
| 1190 | treat-principle | 1 |
| 1191 | treat=11 | 1 |
| 1192 | treat=12.5 | 1 |
| 1193 | treat=16 | 1 |
| 1194 | treat=18 | 1 |
| 1195 | treat=3.22 | 1 |
| 1196 | treat=34 | 1 |
| 1197 | treat=4 | 1 |
| 1198 | treat=40 | 1 |
| 1199 | treat=5.0 | 1 |
| 1200 | treat=5.88 | 1 |
| 1201 | treat=50 | 1 |
| 1202 | treat=7 | 2 |
| 1203 | treat=9 | 3 |
| 1204 | triple-threaded | 5 |
| 1205 | trophins | 2 |
| 1206 | trp159ala | 2 |
| 1207 | ttcms | 2 |
| 1208 | tyr15 | 1 |
| 1209 | underprescription | 3 |
| 1210 | unmed | 3 |
| 1211 | us-ncep | 1 |
| 1212 | vaginal-vault-brachytherapy | 1 |
| 1213 | vamcomycin | 1 |
| 1214 | vandalize | 1 |
| 1215 | vca-p18 | 1 |
| 1216 | vehicle-administration | 1 |
| 1217 | ventilation-perfusion-mismatch | 1 |
| 1218 | ventriculoscopy | 1 |
| 1219 | vernaculars | 1 |
| 1220 | viagra.design | 1 |
| 1221 | vincristine-doxorubicine-dexamethasone | 1 |
| 1222 | vinylsulfidoboron | 4 |
| 1223 | vitebsky | 1 |
| 1224 | vivonex | 1 |
| 1225 | vlcd-programs | 1 |
| 1226 | vo2max. | 1 |
| 1227 | vpa+placebo | 1 |
| 1228 | vsa-pam | 5 |
| 1229 | walk/cycle | 1 |
| 1230 | weight-recovery | 1 |
| 1231 | wertheim-held | 1 |
| 1232 | who/ada | 1 |
| 1233 | width-discontinuity | 1 |
| 1234 | wkw | 1 |
| 1235 | wlcs | 1 |
| 1236 | woman-centredness | 1 |
| 1237 | wood-pasture | 1 |
| 1238 | wr-ai3 | 1 |
| 1239 | wsc1/slg1/hcs77 | 1 |
| 1240 | wu-magnitude | 1 |
| 1241 | x=0.01 | 1 |
| 1242 | xenobitics-metabolizing | 1 |
| 1243 | y.k | 1 |
| 1244 | zidovudine-use | 1 |
| 1245 | ziguinchor | 1 |
| 1246 | ziwu | 2 |
| 1247 | ~9,160 | 1 |
| 1248 | £126,060 | 1 |
| 1249 | £14,959 | 1 |
| 1250 | £26 | 2 |
| 1251 | £31,430 | 1 |
| 1252 | £4733 | 1 |
| 1253 | £590 | 1 |
| 1254 | £662 | 1 |
| 1255 | £71,902 | 1 |
| 1256 | ±4° | 1 |
| 1257 | α-fluoro- | 1 |
| 1258 | β-chitin | 2 |
| 1259 | β-silyl-α | 1 |
| 1260 | β-tridymite | 1 |
| 1261 | βalanlecycmshhex | 1 |
| 1262 | μ39.5 | 1 |
| 1263 | ω-3-pufa | 1 |
| 1264 | ‒0.39 | 1 |
| 1265 | –0.35 | 1 |
| 1266 | €1000 | 2 |
| 1267 | €235.750/qaly | 1 |
| 1268 | €29,000 | 1 |
| 1269 | €3673 | 1 |
| 1270 | €42,271 | 1 |
| 1271 | ∑20pcbs | 2 |
| 1272 | −0.21 | 1 |
| 1273 | −120.19 | 1 |
| 1274 | ∼74°c | 1 |
| 1275 | ≤15ml/s | 1 |
| 1276 | ≤20/30 | 1 |
| 1277 | ≤5° | 3 |
| 1278 | ≤72,000cells/ml | 1 |
| 1279 | ≤89 | 1 |
| 1280 | ≥44°c | 1 |
| 1281 | ⩽4years | 1 |
| 1 | mrt2* | 1 |
| 2 | mace+ | 3 |
| 3 | cldn-1- | 1 |
| 4 | 81- | 1 |
| 5 | drb3- | 1 |
| 6 | 117- | 1 |
| 7 | quinone- | 1 |
| 8 | -spadi- | 1 |
| 9 | α-fluoro- | 1 |
| 10 | k.n. | 1 |
| 11 | vo2max. | 1 |
| 12 | 2510.0 | 1 |
| 13 | 3.6±1.0 | 1 |
| 14 | 12.2+/-4.0 | 1 |
| 15 | treat=5.0 | 1 |
| 16 | 0.20-1.00 | 2 |
| 17 | mean≥3.00 | 2 |
| 18 | 1/1,000,000 | 1 |
| 19 | 170/100,000 | 1 |
| 20 | 1,382/100,000 | 1 |
| 21 | 56.5/100,000 | 1 |
| 22 | 405/100,000 | 1 |
| 23 | n∼45,000 | 1 |
| 24 | euro28,000 | 1 |
| 25 | €29,000 | 1 |
| 26 | 6.00/1000 | 1 |
| 27 | €1000 | 2 |
| 28 | 20/2000 | 1 |
| 29 | loc_os06g226100 | 1 |
| 30 | 12300 | 1 |
| 31 | pound400 | 1 |
| 32 | 13600 | 1 |
| 33 | 1/800 | 2 |
| 34 | 0.44+/-0.10 | 1 |
| 35 | 61.10 | 1 |
| 36 | 8.2/10 | 1 |
| 37 | 10-30-2010 | 1 |
| 38 | december-2010 | 1 |
| 39 | 10/2010 | 1 |
| 40 | 4/30/2010 | 1 |
| 41 | 12/31/2010 | 1 |
| 42 | 2/2010 | 1 |
| 43 | 04/2010 | 1 |
| 44 | 08/2010 | 1 |
| 45 | rs16861210 | 1 |
| 46 | 1.9410 | 1 |
| 47 | 71.20 | 1 |
| 48 | +9.20 | 1 |
| 49 | 5.0/20 | 1 |
| 50 | 1.1020 | 1 |
| 51 | ≤20/30 | 1 |
| 52 | £31,430 | 1 |
| 53 | 2gy×30 | 1 |
| 54 | -32.40 | 1 |
| 55 | 25.140 | 1 |
| 56 | 0.8940 | 1 |
| 57 | treat=40 | 1 |
| 58 | 76.50 | 1 |
| 59 | 869,250 | 1 |
| 60 | 140,350 | 1 |
| 61 | -0.850 | 1 |
| 62 | treat=50 | 1 |
| 63 | £126,060 | 1 |
| 64 | ~9,160 | 1 |
| 65 | 1∶160 | 1 |
| 66 | 57,460 | 1 |
| 67 | 2.660 | 1 |
| 68 | score≤60 | 1 |
| 69 | 114.70 | 1 |
| 70 | 88.70 | 1 |
| 71 | 0.1770 | 1 |
| 72 | tom70 | 1 |
| 73 | achsp70 | 1 |
| 74 | 44/80 | 1 |
| 75 | tcu380 | 2 |
| 76 | -28.90 | 1 |
| 77 | -78.90 | 1 |
| 78 | £590 | 1 |
| 79 | 1:90 | 1 |
| 80 | alr-5iia-1-1 | 1 |
| 81 | chr-1 | 1 |
| 82 | 31.3+/-3.1 | 1 |
| 83 | 13.8±13.1 | 1 |
| 84 | 6.0±3.1 | 1 |
| 85 | 694.1 | 1 |
| 86 | 57.6±4.1 | 1 |
| 87 | 98.5±28.1 | 1 |
| 88 | 43.3±29.1 | 1 |
| 89 | x=0.01 | 1 |
| 90 | 10/2001 | 1 |
| 91 | 31/10/2001 | 1 |
| 92 | 06/2001 | 1 |
| 93 | 07/2001 | 3 |
| 94 | 09/2001 | 1 |
| 95 | 10/12001 | 1 |
| 96 | st-101 | 1 |
| 97 | 0.40+/-0.11 | 1 |
| 98 | 172.11 | 1 |
| 99 | 01/11 | 1 |
| 100 | hpv-6/11 | 2 |
| 101 | december-2011 | 1 |
| 102 | 30.12.2011 | 1 |
| 103 | 03/31/2011 | 2 |
| 104 | a/duck/quangngai/1037/2011 | 1 |
| 105 | 2010–2011 | 1 |
| 106 | 8167±3111 | 1 |
| 107 | treat=11 | 1 |
| 108 | hb-21 | 1 |
| 109 | pnd-21 | 1 |
| 110 | −0.21 | 1 |
| 111 | 16q21 | 1 |
| 112 | qsy21 | 1 |
| 113 | 2005/12/31 | 1 |
| 114 | 2007/12/31 | 1 |
| 115 | -0.141 | 2 |
| 116 | 1.3441 | 1 |
| 117 | 8.741 | 1 |
| 118 | 231.51 | 1 |
| 119 | -279.51 | 1 |
| 120 | 0.3151 | 1 |
| 121 | 0.2651 | 1 |
| 122 | -1·51 | 2 |
| 123 | 5.36+/-0.61 | 1 |
| 124 | 21.70+/-9.61 | 1 |
| 125 | €42,271 | 1 |
| 126 | 11.981 | 1 |
| 127 | cys191 | 1 |
| 128 | 18.0:1 | 1 |
| 129 | 5.1:1 | 1 |
| 130 | hph1 | 1 |
| 131 | cmt1 | 1 |
| 132 | january1 | 1 |
| 133 | 23±1 | 1 |
| 134 | 29±1 | 4 |
| 135 | 5.14+/-2 | 1 |
| 136 | argonaute-2 | 1 |
| 137 | 121.6±8.2 | 1 |
| 138 | 2559.2 | 1 |
| 139 | heat.2 | 1 |
| 140 | 2003-02 | 1 |
| 141 | 6.94±4.02 | 1 |
| 142 | 78.02 | 1 |
| 143 | 2000/02 | 1 |
| 144 | -702 | 1 |
| 145 | 5.3702 | 1 |
| 146 | £71,902 | 1 |
| 147 | 1,110.12 | 1 |
| 148 | 9/30/12 | 1 |
| 149 | 12/15/2012 | 1 |
| 150 | 6/2012 | 1 |
| 151 | 08/2012 | 2 |
| 152 | 30/08/2012 | 1 |
| 153 | 4.112 | 1 |
| 154 | 0.1212 | 1 |
| 155 | 8512 | 1 |
| 156 | 80.22 | 1 |
| 157 | 0.39±0.22 | 1 |
| 158 | -32.22 | 2 |
| 159 | treat=3.22 | 1 |
| 160 | euro122 | 1 |
| 161 | 1.322 | 1 |
| 162 | -27.32 | 1 |
| 163 | 1.27±0.42 | 1 |
| 164 | -117.42 | 1 |
| 165 | 1.00±0.52 | 1 |
| 166 | -261.52 | 1 |
| 167 | 537.52 | 1 |
| 168 | pound154,752 | 1 |
| 169 | c52 | 1 |
| 170 | 1.93±0.62 | 1 |
| 171 | -45.62 | 1 |
| 172 | -137.62 | 1 |
| 173 | £662 | 1 |
| 174 | 55.72 | 1 |
| 175 | -27.72 | 1 |
| 176 | 3.772 | 1 |
| 177 | 18381+/-1772 | 1 |
| 178 | -300.82 | 1 |
| 179 | 291.82 | 1 |
| 180 | -27.82 | 1 |
| 181 | 10782 | 1 |
| 182 | -207.92 | 1 |
| 183 | ie2 | 1 |
| 184 | 30±6kg/m2 | 1 |
| 185 | tcs2 | 2 |
| 186 | cpl1/fiery2 | 1 |
| 187 | +5·2 | 1 |
| 188 | 24:5n-3 | 6 |
| 189 | -2.00+/-0.3 | 1 |
| 190 | 1:0.3 | 1 |
| 191 | 2.5±1.3 | 1 |
| 192 | 117.9±1.3 | 1 |
| 193 | -103.3 | 1 |
| 194 | 886.3 | 1 |
| 195 | 409.3 | 1 |
| 196 | normal.3 | 1 |
| 197 | 1,265.03 | 1 |
| 198 | t-13 | 1 |
| 199 | 8.67±2.13 | 1 |
| 200 | -78.13 | 1 |
| 201 | march-2013 | 1 |
| 202 | mar.2013 | 1 |
| 203 | 7/1/2013 | 1 |
| 204 | 30/october/2013 | 1 |
| 205 | -213 | 1 |
| 206 | 34.713 | 1 |
| 207 | 1.17+/-0.23 | 3 |
| 208 | 1.2323 | 1 |
| 209 | 11q22.3-q23 | 1 |
| 210 | 11q21q23 | 1 |
| 211 | 0.60±0.33 | 1 |
| 212 | £4733 | 1 |
| 213 | +3.53 | 1 |
| 214 | cris-153 | 1 |
| 215 | 0.7653 | 2 |
| 216 | 1.93±0.63 | 1 |
| 217 | -42.63 | 1 |
| 218 | -65.63 | 1 |
| 219 | -0.163 | 1 |
| 220 | 16.83±4.73 | 1 |
| 221 | m173 | 1 |
| 222 | €3673 | 1 |
| 223 | +4.93 | 1 |
| 224 | 11/19/93 | 1 |
| 225 | libaf3 | 1 |
| 226 | wr-ai3 | 1 |
| 227 | 15,000/mm3 | 2 |
| 228 | nprup3 | 1 |
| 229 | pam-nt3 | 1 |
| 230 | 12.3+/-4 | 1 |
| 231 | 5x10-4 | 1 |
| 232 | 11.5-4 | 1 |
| 233 | ckd-4 | 3 |
| 234 | 29.1+/-1.4 | 1 |
| 235 | 43.3+/-3.4 | 1 |
| 236 | 296.4 | 1 |
| 237 | 18.5±7.4 | 1 |
| 238 | 0.10+/-0.04 | 1 |
| 239 | -0.11+/-0.04 | 1 |
| 240 | 0.86+/-0.04 | 1 |
| 241 | -35.04 | 1 |
| 242 | 17.004 | 1 |
| 243 | 0.8304 | 1 |
| 244 | ser404 | 1 |
| 245 | 337.785±84.504 | 1 |
| 246 | 4·04 | 1 |
| 247 | 134.14 | 1 |
| 248 | -8.14 | 1 |
| 249 | 01/01/2014 | 1 |
| 250 | june2014 | 1 |
| 251 | pod14 | 1 |
| 252 | day14 | 1 |
| 253 | 107.24 | 1 |
| 254 | 245,724 | 1 |
| 255 | 13.824 | 1 |
| 256 | hivp24 | 1 |
| 257 | 1.0134 | 1 |
| 258 | 8.334 | 1 |
| 259 | treat=34 | 1 |
| 260 | 1.44+/-0.44 | 1 |
| 261 | phospho-s1444 | 2 |
| 262 | 1.844 | 1 |
| 263 | -197.54 | 1 |
| 264 | 222.054 | 1 |
| 265 | bde-154 | 2 |
| 266 | 10.254 | 1 |
| 267 | 5.354 | 1 |
| 268 | 3.464 | 1 |
| 269 | 706.74 | 1 |
| 270 | 187.74 | 1 |
| 271 | 2.474 | 1 |
| 272 | 231.84 | 1 |
| 273 | 108.84 | 1 |
| 274 | 1.684 | 2 |
| 275 | 6.684 | 1 |
| 276 | 31-12-94 | 1 |
| 277 | -10.94 | 2 |
| 278 | 02/11/94 | 1 |
| 279 | december/94 | 1 |
| 280 | pn-n-1307:1994 | 1 |
| 281 | treat=4 | 1 |
| 282 | sr2ruo4 | 1 |
| 283 | aflp4 | 1 |
| 284 | 14.1±4 | 1 |
| 285 | 26.8±4 | 1 |
| 286 | loe-5 | 1 |
| 287 | 156.9/81.5 | 1 |
| 288 | treat=12.5 | 1 |
| 289 | 8.7±2.5 | 1 |
| 290 | 675.5 | 1 |
| 291 | μ39.5 | 1 |
| 292 | 0.36±0.05 | 1 |
| 293 | ni/w/sba-15 | 1 |
| 294 | 157.15 | 1 |
| 295 | 7.215 | 1 |
| 296 | tyr15 | 1 |
| 297 | –0.35 | 1 |
| 298 | 2.0035 | 1 |
| 299 | a=135 | 1 |
| 300 | 1.735 | 1 |
| 301 | 5.935 | 1 |
| 302 | 65.935 | 1 |
| 303 | 56±35 | 1 |
| 304 | 3.345 | 1 |
| 305 | 1.93-4.55 | 1 |
| 306 | 0.1455 | 1 |
| 307 | d365 | 1 |
| 308 | 41.75 | 2 |
| 309 | 219,775 | 1 |
| 310 | 7.97+/-0.85 | 1 |
| 311 | 167.85 | 1 |
| 312 | 3.485 | 1 |
| 313 | st85 | 1 |
| 314 | -265.95 | 1 |
| 315 | 68.95 | 1 |
| 316 | december，1995 | 1 |
| 317 | slt5 | 3 |
| 318 | pgy-6 | 1 |
| 319 | 2.8±1.6 | 1 |
| 320 | 17.5±2.6 | 1 |
| 321 | 64.6±23.6 | 1 |
| 322 | +36.6 | 1 |
| 323 | 386.6 | 1 |
| 324 | carvedilol.6 | 1 |
| 325 | 1.2±0.06 | 1 |
| 326 | 2013/06 | 1 |
| 327 | 05/2006 | 1 |
| 328 | 4-8/4-16 | 1 |
| 329 | 0.000016 | 1 |
| 330 | 3.816 | 1 |
| 331 | treat=16 | 1 |
| 332 | 77.26 | 1 |
| 333 | -0.02526 | 1 |
| 334 | £26 | 2 |
| 335 | 101±26 | 1 |
| 336 | -30.36 | 1 |
| 337 | arg346 | 1 |
| 338 | 5.446 | 1 |
| 339 | 112.56 | 1 |
| 340 | 0.2056 | 1 |
| 341 | 21,956 | 1 |
| 342 | -41.66 | 1 |
| 343 | 393.66 | 1 |
| 344 | -0.2066 | 1 |
| 345 | h266 | 1 |
| 346 | 250,286 | 1 |
| 347 | 90.96 | 1 |
| 348 | -33.96 | 1 |
| 349 | 1254.96 | 1 |
| 350 | -138.96 | 1 |
| 351 | fac6 | 1 |
| 352 | htg6 | 1 |
| 353 | c57black6 | 1 |
| 354 | 4.4+/-0.7 | 1 |
| 355 | 2.2±0.7 | 4 |
| 356 | fhcd59-1.7 | 1 |
| 357 | -224.7 | 1 |
| 358 | 45.1+/-9.7 | 1 |
| 359 | 0.12+/-0.07 | 1 |
| 360 | -27.07 | 1 |
| 361 | -9.07 | 1 |
| 362 | 4.007 | 1 |
| 363 | 12/31/2007 | 1 |
| 364 | 31/7/2007 | 1 |
| 365 | 12.407 | 1 |
| 366 | 0.9807 | 1 |
| 367 | 9596±3907 | 1 |
| 368 | 83.17 | 2 |
| 369 | 107±17 | 1 |
| 370 | m=1.27 | 1 |
| 371 | 189.37 | 1 |
| 372 | 199.37 | 1 |
| 373 | 0.00337 | 1 |
| 374 | -97.47 | 1 |
| 375 | 101.57 | 1 |
| 376 | cgp37157 | 1 |
| 377 | -195.67 | 1 |
| 378 | 3,067 | 1 |
| 379 | 262,567 | 1 |
| 380 | ap24567 | 3 |
| 381 | -29.77 | 1 |
| 382 | -£477 | 1 |
| 383 | wsc1/slg1/hcs77 | 1 |
| 384 | -106.87 | 1 |
| 385 | 383.97 | 1 |
| 386 | march/97 | 1 |
| 387 | 5.1997 | 1 |
| 388 | treat=7 | 2 |
| 389 | pn7 | 2 |
| 390 | gal-8 | 2 |
| 391 | 3.7±1.8 | 1 |
| 392 | 7.6+/-2.8 | 1 |
| 393 | 7.9±2.8 | 1 |
| 394 | 19.4±3.8 | 1 |
| 395 | 31.3±6.8 | 1 |
| 396 | 1,08 | 1 |
| 397 | 0.56+/-0.08 | 1 |
| 398 | 301.08 | 1 |
| 399 | gb16889-2008 | 1 |
| 400 | 1.1208 | 1 |
| 401 | -5.408 | 1 |
| 402 | rh0808 | 1 |
| 403 | 31+/-18 | 1 |
| 404 | 46+/-18 | 1 |
| 405 | -0.0.18 | 1 |
| 406 | 21.60+/-10.18 | 1 |
| 407 | 2.718 | 1 |
| 408 | 2.918 | 1 |
| 409 | treat=18 | 1 |
| 410 | ppatg18 | 1 |
| 411 | vca-p18 | 1 |
| 412 | 101.28 | 1 |
| 413 | 13,928 | 1 |
| 414 | -10.38 | 2 |
| 415 | 24.38 | 2 |
| 416 | -0.138 | 2 |
| 417 | 1.538 | 2 |
| 418 | 2.738 | 1 |
| 419 | sn38 | 2 |
| 420 | -17.48 | 1 |
| 421 | 1.0848 | 1 |
| 422 | -15.58 | 1 |
| 423 | -0.558 | 1 |
| 424 | 5.858 | 1 |
| 425 | 24:58 | 1 |
| 426 | 55.68 | 1 |
| 427 | 239.68 | 2 |
| 428 | 212.78 | 1 |
| 429 | -42.78 | 1 |
| 430 | 0.5178 | 1 |
| 431 | treat=5.88 | 1 |
| 432 | 147/88 | 1 |
| 433 | 1.388 | 1 |
| 434 | 2.588 | 1 |
| 435 | acra8 | 1 |
| 436 | pnd8 | 1 |
| 437 | 45.4±0.9 | 1 |
| 438 | 3.37±0.9 | 1 |
| 439 | 4.0/1.9 | 1 |
| 440 | 212.9 | 1 |
| 441 | 343.9 | 1 |
| 442 | 14.3±4.9 | 1 |
| 443 | 27/11/09 | 1 |
| 444 | 12/22/09 | 1 |
| 445 | 09-jan-2009 | 1 |
| 446 | 12/31/2009 | 1 |
| 447 | 1/6/2009 | 1 |
| 448 | december/2009 | 1 |
| 449 | 10,809 | 1 |
| 450 | 7·09 | 1 |
| 451 | −120.19 | 1 |
| 452 | 1.90±0.29 | 1 |
| 453 | 0.91±0.29 | 1 |
| 454 | 2.05±0.29 | 1 |
| 455 | 179.29 | 1 |
| 456 | 0.00229 | 1 |
| 457 | -1,429 | 1 |
| 458 | 60.39 | 1 |
| 459 | ‒0.39 | 1 |
| 460 | -116.39 | 1 |
| 461 | -2.339 | 1 |
| 462 | 2.739 | 1 |
| 463 | 260.49 | 1 |
| 464 | -35.49 | 1 |
| 465 | -1.049 | 1 |
| 466 | ser49/ser49 | 1 |
| 467 | -16.59 | 1 |
| 468 | £14,959 | 1 |
| 469 | 1833.69 | 1 |
| 470 | -257.69 | 1 |
| 471 | 1:2569 | 1 |
| 472 | 2.37±0.79 | 1 |
| 473 | 13.48+/-1.79 | 1 |
| 474 | 125.79 | 1 |
| 475 | -27.79 | 1 |
| 476 | 4479 | 1 |
| 477 | 23,679 | 1 |
| 478 | -212.89 | 1 |
| 479 | 33.3±2.89 | 1 |
| 480 | -65.89 | 1 |
| 481 | 117.89 | 1 |
| 482 | 7.789 | 1 |
| 483 | ≤89 | 1 |
| 484 | 403.99 | 1 |
| 485 | 0.00399 | 1 |
| 486 | 12/1999 | 1 |
| 487 | treat=9 | 3 |
| 488 | rbc-c-a | 2 |
| 489 | ken-a | 1 |
| 490 | er-a | 1 |
| 491 | k.b.a | 1 |
| 492 | 794aa | 1 |
| 493 | mzimba | 1 |
| 494 | who/ada | 1 |
| 495 | al-hada | 1 |
| 496 | chaetonotida | 1 |
| 497 | macrodasyida | 1 |
| 498 | 10.77kda | 1 |
| 499 | tambacunda | 1 |
| 500 | bpda | 4 |
| 501 | oligoamucorrhea | 1 |
| 502 | fatigue/nausea | 1 |
| 503 | disc/fovea | 1 |
| 504 | ω-3-pufa | 1 |
| 505 | phocomelia | 1 |
| 506 | colisepticaemia | 1 |
| 507 | hypertension/dyslipidaemia | 1 |
| 508 | asthenoteratospermia | 1 |
| 509 | se-asia | 1 |
| 510 | ad/dementia | 5 |
| 511 | hodja | 2 |
| 512 | trp159ala | 2 |
| 513 | metula | 1 |
| 514 | 3/fistula | 1 |
| 515 | hgd/adenocarcinoma | 1 |
| 516 | eachketena | 1 |
| 517 | oxalyl-coa | 1 |
| 518 | tcu-pa | 3 |
| 519 | ophiocara | 1 |
| 520 | episclera | 2 |
| 521 | mandibulata | 1 |
| 522 | pyrenochaeta | 1 |
| 523 | 29.7delta | 1 |
| 524 | mandya | 1 |
| 525 | 8.5×1011b | 1 |
| 526 | ifnalpha-2b | 1 |
| 527 | barc-3b | 1 |
| 528 | fra3b | 1 |
| 529 | spmab | 1 |
| 530 | hemadsorb | 1 |
| 531 | 15asb | 1 |
| 532 | ecasa+c | 1 |
| 533 | mex3c | 1 |
| 534 | mtz-plac | 2 |
| 535 | d2cc | 1 |
| 536 | cirrhosis-hcc | 1 |
| 537 | jírovec | 1 |
| 538 | 38.7dgc | 1 |
| 539 | events-angiographic | 1 |
| 540 | acidiphilic | 1 |
| 541 | non-pharmacodynamic | 1 |
| 542 | amoxicillin-clavunanic | 1 |
| 543 | s/plc | 1 |
| 544 | 3tc/ftc | 2 |
| 545 | 90+°c | 1 |
| 546 | 43.0°c | 2 |
| 547 | 94.0°c | 1 |
| 548 | 5.00°c | 1 |
| 549 | 1150°c | 1 |
| 550 | 560°c | 1 |
| 551 | 53.1°c | 1 |
| 552 | 93.1°c | 1 |
| 553 | 5.21°c | 1 |
| 554 | 5.2°c | 1 |
| 555 | 112°c | 1 |
| 556 | 71.72°c | 1 |
| 557 | -22.9±0.3°c | 1 |
| 558 | 13.03°c | 1 |
| 559 | 263°c | 1 |
| 560 | 112.4°c | 1 |
| 561 | ≥44°c | 1 |
| 562 | ∼74°c | 1 |
| 563 | 59.5°c | 1 |
| 564 | -25°c | 1 |
| 565 | 0.35°c | 3 |
| 566 | 245°c | 1 |
| 567 | 2245°c | 1 |
| 568 | 93.6°c | 1 |
| 569 | 3.36°c | 1 |
| 570 | 156°c | 1 |
| 571 | 18.17°c | 1 |
| 572 | 4.58°c | 1 |
| 573 | 109°c | 1 |
| 574 | 35-29°c | 1 |
| 575 | 41,7ºc | 1 |
| 576 | +2.00d | 1 |
| 577 | 9-oh-add | 1 |
| 578 | triple-threaded | 5 |
| 579 | angiographic-guided | 1 |
| 580 | declassified | 2 |
| 581 | calculed | 1 |
| 582 | unmed | 3 |
| 583 | non-warmed | 1 |
| 584 | non-oestrogen-treated | 1 |
| 585 | annelida-dominated | 1 |
| 586 | locally-generated | 1 |
| 587 | application-oriented | 1 |
| 588 | defragmented | 1 |
| 589 | wertheim-held | 1 |
| 590 | 4-6-month-old | 1 |
| 591 | 24-years-old | 1 |
| 592 | 48-years-old | 1 |
| 593 | 15-y-old | 2 |
| 594 | 3.53-fold | 1 |
| 595 | 414-fold | 1 |
| 596 | 5.34-fold | 1 |
| 597 | 0.74-fold | 1 |
| 598 | 58.9-fold | 1 |
| 599 | fansler-arnold | 1 |
| 600 | resend | 1 |
| 601 | leonhard | 1 |
| 602 | post-think-aloud | 1 |
| 603 | pre-rvd | 1 |
| 604 | pseudopulicidae | 1 |
| 605 | cowardice | 1 |
| 606 | non-avoidance | 1 |
| 607 | prerace-performance | 1 |
| 608 | rejection/acceptance | 1 |
| 609 | fhb-resistance | 1 |
| 610 | gaze-assistance | 1 |
| 611 | immunity/defence | 1 |
| 612 | immuno-incompetence | 2 |
| 613 | biopersistence | 2 |
| 614 | deliquesce | 1 |
| 615 | defervesce | 5 |
| 616 | p38-blockade | 1 |
| 617 | aldophosphamide | 1 |
| 618 | dimethylacrylamide | 1 |
| 619 | dihydroergotamine/metoclopramide | 2 |
| 620 | ergosteryl-3β-glucoside | 1 |
| 621 | methanediazohydroxide | 1 |
| 622 | atenolol/bendroflumethiazide | 1 |
| 623 | attention/default-mode | 1 |
| 624 | wu-magnitude | 1 |
| 625 | counsellee | 2 |
| 626 | récurettage | 1 |
| 627 | r-chop-ie | 1 |
| 628 | hsp110-like | 1 |
| 629 | d-penicillamine-like | 1 |
| 630 | citrus-like | 1 |
| 631 | photonlike | 1 |
| 632 | walk/cycle | 1 |
| 633 | cisplatinum-5-fluoro-uracile | 1 |
| 634 | semiprofile | 1 |
| 635 | partington-rochelle | 1 |
| 636 | itrazonazole | 1 |
| 637 | treat-principle | 1 |
| 638 | fe2+-heme | 1 |
| 639 | fourtheme | 2 |
| 640 | time-to-time | 1 |
| 641 | overconsume | 1 |
| 642 | steradiene | 1 |
| 643 | 1-cyano-1,3-butadiene | 2 |
| 644 | cis-3-hexene | 3 |
| 645 | ciproflaxacine | 1 |
| 646 | gatifloxacine | 1 |
| 647 | procline | 1 |
| 648 | tethracycline | 1 |
| 649 | medicus/medline | 3 |
| 650 | acetycholine | 1 |
| 651 | 2-methylpyrroline | 1 |
| 652 | isolg-ethanolamine | 1 |
| 653 | arabinosylthymine | 2 |
| 654 | ademe-thionine | 1 |
| 655 | lithium/valproate/carbamazepine | 1 |
| 656 | 8-nitroguanosine | 1 |
| 657 | clandes-tine | 1 |
| 658 | cefoxitine | 2 |
| 659 | adoprazine | 1 |
| 660 | 3β-acetoxy-16-methylene-androst-5-en-17-one | 1 |
| 661 | face/telephone | 1 |
| 662 | 5α-androstanedione-3,17-dione | 1 |
| 663 | mild/none | 1 |
| 664 | e2-3,4-quinone | 1 |
| 665 | mitxantrone | 1 |
| 666 | vincristine-doxorubicine-dexamethasone | 1 |
| 667 | a.oryzoe | 1 |
| 668 | dexamethasone.there | 1 |
| 669 | 9.therefore | 1 |
| 670 | cardiocentre | 1 |
| 671 | alprazolam-exposure | 1 |
| 672 | pinch/pressure | 1 |
| 673 | anthropopressure | 1 |
| 674 | endovasculature | 1 |
| 675 | tcm/acupuncture | 1 |
| 676 | wood-pasture | 1 |
| 677 | condensed-phase | 2 |
| 678 | re-anesthetise | 1 |
| 679 | diabetes.acarbose | 1 |
| 680 | dtdp-3-keto-6-deoxyglucose | 1 |
| 681 | re-dose | 3 |
| 682 | eclose | 1 |
| 683 | tc+tse | 1 |
| 684 | zidovudine-use | 1 |
| 685 | extubate | 28 |
| 686 | date | 7,450 |
| 687 | metylphenidate | 1 |
| 688 | co-create | 1 |
| 689 | procreate | 5 |
| 690 | chondroitin-4-sulphate | 1 |
| 691 | mevalonate-3-phosphate | 1 |
| 692 | sedoheptulose-7-phosphate | 1 |
| 693 | phosphatidylinositol-3,4,5-triphosphate | 2 |
| 694 | osmoregulate | 1 |
| 695 | decannulate | 2 |
| 696 | iso-amyl-cyanoacrylate | 1 |
| 697 | 4-hydroxyphenylglyoxylate | 1 |
| 698 | stagnate | 1 |
| 699 | self-vaccinate | 1 |
| 700 | pollinate | 1 |
| 701 | phonate | 1 |
| 702 | 4-methylvalerate | 1 |
| 703 | incinerate | 1 |
| 704 | reoperate | 1 |
| 705 | 4-hydroxy-2-ketobutyrate | 2 |
| 706 | 2-acetolactate | 1 |
| 707 | clavate | 1 |
| 708 | acetopyruvate | 1 |
| 709 | clear-white | 1 |
| 710 | β-tridymite | 1 |
| 711 | 'cigarette | 1 |
| 712 | myocardiacyte | 1 |
| 713 | vandalize | 1 |
| 714 | subspecialize | 1 |
| 715 | re-epithelialize | 3 |
| 716 | cellularize | 1 |
| 717 | homodimerize | 1 |
| 718 | epimerize | 1 |
| 719 | self-catheterize | 2 |
| 720 | l10f | 1 |
| 721 | -3f | 1 |
| 722 | lights-off | 1 |
| 723 | at→cmf | 1 |
| 724 | biodiesels-wsf | 1 |
| 725 | 101.4°f | 1 |
| 726 | 40-60g | 1 |
| 727 | 4.5-6g | 1 |
| 728 | 46.0fg | 1 |
| 729 | 4.5mmhg | 1 |
| 730 | 78+/-8mmhg | 1 |
| 731 | 0.15w/kg | 1 |
| 732 | 84.4kg | 1 |
| 733 | 1.9kg | 1 |
| 734 | pakg | 1 |
| 735 | 0.81nmol/min/mg | 1 |
| 736 | 1.54nmol/min/mg | 1 |
| 737 | 2895.53mg | 1 |
| 738 | 85.6.8+/-7.6mg | 1 |
| 739 | 1162+/-79mg | 1 |
| 740 | bottlefeeding | 1 |
| 741 | shelter-providing | 1 |
| 742 | shellfishing | 1 |
| 743 | pretzel-baking | 1 |
| 744 | level-walking | 1 |
| 745 | face-to-face-programming | 1 |
| 746 | brining | 2 |
| 747 | pretensioning | 5 |
| 748 | question-answering | 1 |
| 749 | na-processing | 1 |
| 750 | plus-crossing | 1 |
| 751 | re-operating | 1 |
| 752 | overcollecting | 1 |
| 753 | ptca/stenting | 1 |
| 754 | accurate-reporting | 2 |
| 755 | over-harvesting | 2 |
| 756 | population/setting | 1 |
| 757 | xenobitics-metabolizing | 1 |
| 758 | ntng | 1 |
| 759 | gsg | 3 |
| 760 | okt3/atg | 1 |
| 761 | -10.3/h | 1 |
| 762 | 9/h | 1 |
| 763 | 5°c/h | 1 |
| 764 | 28.46±8.24nmol/μg/h | 1 |
| 765 | 56h | 1 |
| 766 | -8h | 1 |
| 767 | pep-speech | 1 |
| 768 | belch | 17 |
| 769 | ventilation-perfusion-mismatch | 1 |
| 770 | attempts-much | 1 |
| 771 | no-ufh | 1 |
| 772 | 1107.76μg/mlh | 1 |
| 773 | -ssh | 1 |
| 774 | 40°c/exh | 1 |
| 775 | ang-i | 1 |
| 776 | lt-i | 6 |
| 777 | cdai/sdai | 1 |
| 778 | fefdbi | 1 |
| 779 | liberase-hi | 1 |
| 780 | ii-ii | 1 |
| 781 | diverticuli | 2 |
| 782 | mf-mpi | 1 |
| 783 | iasi | 8 |
| 784 | gonzales-crussi | 1 |
| 785 | nazzi | 1 |
| 786 | y.k | 1 |
| 787 | 310k | 1 |
| 788 | 575k | 1 |
| 789 | overdrink | 1 |
| 790 | time-off-work | 1 |
| 791 | 100×10/l | 1 |
| 792 | 58.4g/l | 1 |
| 793 | 4000mg/l | 1 |
| 794 | 2.2±2.4mg/l | 1 |
| 795 | 2.30ng/l | 1 |
| 796 | 92.0±40.5mmol/l | 1 |
| 797 | 278±14nmol/l | 1 |
| 798 | 302±15nmol/l | 1 |
| 799 | 8.7/micromol/l | 1 |
| 800 | 49.4±21.0µmol/l | 1 |
| 801 | 73.8±23.3µmol/l | 1 |
| 802 | high/normal | 1 |
| 803 | nicu/hospital | 1 |
| 804 | 3-day-plaque-regrowth-interval | 1 |
| 805 | fty-bl | 4 |
| 806 | c-cbl | 1 |
| 807 | ch2fcd2cl | 2 |
| 808 | 280mg/dl | 1 |
| 809 | 231.0+/-3.2mg/dl | 1 |
| 810 | control-hdl | 1 |
| 811 | tezampanel | 1 |
| 812 | follow-up.overall | 1 |
| 813 | 120/ml | 1 |
| 814 | 17/ml | 1 |
| 815 | 12.5mg/ml | 1 |
| 816 | 2.28mg/ml | 1 |
| 817 | 0.049mg/ml | 1 |
| 818 | 5000.00ng/ml | 1 |
| 819 | 1000ng/ml | 3 |
| 820 | 19.9±27.5ng/ml | 1 |
| 821 | 5.5±4.9ng/ml | 1 |
| 822 | 2.3±2.0pg/ml | 1 |
| 823 | 48.0pg/ml | 1 |
| 824 | 225±137pg/ml | 1 |
| 825 | 86.35µg/ml | 1 |
| 826 | 22.36µg/ml | 1 |
| 827 | 2048µg/ml | 1 |
| 828 | 71.570±4.324μg/ml | 1 |
| 829 | 0.93±0.27μg/ml | 1 |
| 830 | 18.72±0.78μg/ml | 1 |
| 831 | 1.25µl/ml | 1 |
| 832 | 99.3±15.1μmol/min/ml | 1 |
| 833 | ≤72,000cells/ml | 1 |
| 834 | 0.6logcfu/ml | 1 |
| 835 | 32.2ml | 1 |
| 836 | tiamphenicol | 1 |
| 837 | chlormphenicol | 1 |
| 838 | neutral/menthol | 1 |
| 839 | pentanethiol | 1 |
| 840 | 1-dodecanol | 2 |
| 841 | 2,5-furandimethanol | 1 |
| 842 | efmtool | 1 |
| 843 | fecosterol | 1 |
| 844 | hfd-control | 1 |
| 845 | sligrl | 2 |
| 846 | 75,500/µl | 1 |
| 847 | 5355±1257/µl | 1 |
| 848 | 9.0m | 1 |
| 849 | 3700m | 1 |
| 850 | 71.3m | 1 |
| 851 | 1.35m | 1 |
| 852 | 11:00am | 2 |
| 853 | indisulam | 2 |
| 854 | vsa-pam | 5 |
| 855 | levcromakalim | 1 |
| 856 | sulfamethoxazole/trimetoprim | 1 |
| 857 | cephotaxim | 2 |
| 858 | -0.009mm | 1 |
| 859 | 0.11db/nm | 1 |
| 860 | 2400nm | 1 |
| 861 | 0.2nm | 1 |
| 862 | 22nm | 1 |
| 863 | 3.5nm | 1 |
| 864 | 55nm | 1 |
| 865 | 676nm | 1 |
| 866 | 7.7nm | 1 |
| 867 | 28nm | 1 |
| 868 | enets-tnm | 1 |
| 869 | endomondo.com | 1 |
| 870 | 47,600ppm | 1 |
| 871 | 20ppm | 1 |
| 872 | sharmanism | 1 |
| 873 | antibioterrorism | 1 |
| 874 | 78°c≈tm | 1 |
| 875 | dauricum | 2 |
| 876 | tocolyticum | 1 |
| 877 | azepanium | 1 |
| 878 | imipenum | 1 |
| 879 | antero-septum | 1 |
| 880 | olinda|exm | 2 |
| 881 | 600μm | 4 |
| 882 | 11μm | 1 |
| 883 | 9.73μm | 1 |
| 884 | 0.244μm | 1 |
| 885 | 15.64μm | 1 |
| 886 | 25.94μm | 1 |
| 887 | 38.5μm | 1 |
| 888 | h.n | 1 |
| 889 | avgtmean | 2 |
| 890 | seomulyuchan | 2 |
| 891 | jiejian | 1 |
| 892 | steadman | 1 |
| 893 | placebo/dextran | 1 |
| 894 | target-screen | 1 |
| 895 | 6-oxygen | 1 |
| 896 | nylen | 1 |
| 897 | paracrine-driven | 1 |
| 898 | viagra.design | 1 |
| 899 | bleeding/pain | 11 |
| 900 | erucin | 4 |
| 901 | vamcomycin | 1 |
| 902 | 3,4,3',4'-tetrahydrospirilloxanthin | 1 |
| 903 | 0.01/min | 1 |
| 904 | 40k/min | 1 |
| 905 | 2120ml/min | 1 |
| 906 | 72±8beats/min | 1 |
| 907 | 50min | 4 |
| 908 | 72min | 1 |
| 909 | b-albumin | 1 |
| 910 | nitrofuraintoin | 1 |
| 911 | colerin | 1 |
| 912 | β-chitin | 2 |
| 913 | hanatoxin | 1 |
| 914 | martentoxin | 1 |
| 915 | cephtizoxin | 1 |
| 916 | hb-koln | 1 |
| 917 | cntln | 2 |
| 918 | ethephon | 4 |
| 919 | li-diffusion | 1 |
| 920 | injury/reperfusion | 3 |
| 921 | toxin-degradation | 1 |
| 922 | sialilation | 1 |
| 923 | ifn-α-stimulation | 1 |
| 924 | trans-autophosphorylation | 2 |
| 925 | hypoxia-re-oxygenation | 1 |
| 926 | anoxia-reoxygenation | 2 |
| 927 | hexacoordination | 1 |
| 928 | self-agglutination | 1 |
| 929 | non-anticipation | 1 |
| 930 | injection-aspiration | 1 |
| 931 | vehicle-administration | 1 |
| 932 | chemoimmobilisation | 1 |
| 933 | mini-hlm-revascularisation | 1 |
| 934 | acclimatisation/adaptation | 1 |
| 935 | adaptation/habituation | 1 |
| 936 | photo-sensibilization | 1 |
| 937 | radiosterilization | 2 |
| 938 | euthanization | 5 |
| 939 | pml-multimerization | 1 |
| 940 | monochromatization | 1 |
| 941 | autoinfection | 1 |
| 942 | ctx-injection | 1 |
| 943 | d0/1-dissection | 1 |
| 944 | self-reproduction | 1 |
| 945 | mucosecretion | 1 |
| 946 | fruition | 7 |
| 947 | underprescription | 3 |
| 948 | 2,6-disubstitution | 1 |
| 949 | vinylsulfidoboron | 4 |
| 950 | tinyurl.com/pggfrwn | 1 |
| 951 | marañón | 5 |
| 952 | 8-10cmh2o | 1 |
| 953 | plabebo | 1 |
| 954 | pio+lacebo | 1 |
| 955 | vpa+placebo | 1 |
| 956 | hfd+placebo | 1 |
| 957 | 0-placebo | 1 |
| 958 | amdo | 1 |
| 959 | hunt-lawrence-rodino | 1 |
| 960 | en/iso | 1 |
| 961 | mopotsyo | 1 |
| 962 | sse1p | 1 |
| 963 | sham-pap | 2 |
| 964 | 3420bp | 1 |
| 965 | 290bp | 1 |
| 966 | d-glcp | 1 |
| 967 | us-ncep | 1 |
| 968 | sleeep | 1 |
| 969 | housekeep | 1 |
| 970 | 'slip | 1 |
| 971 | baseline/mp | 1 |
| 972 | 2'-amp/3'-amp | 1 |
| 973 | hgkrp | 1 |
| 974 | mn-gtp | 1 |
| 975 | eotp | 3 |
| 976 | rex-group | 2 |
| 977 | erlotinib/hcq | 1 |
| 978 | end-r | 3 |
| 979 | a.r | 1 |
| 980 | 58.2/100,000/year | 1 |
| 981 | bhubaneswar | 1 |
| 982 | finnger | 1 |
| 983 | blumberger | 1 |
| 984 | 17alpha-cyanomethyl-estradoil-3-methylether | 1 |
| 985 | craig-walker | 1 |
| 986 | 7mer | 1 |
| 987 | krimmer | 1 |
| 988 | 0.96.however | 1 |
| 989 | placebo.however | 1 |
| 990 | adults.moreover | 1 |
| 991 | passover | 2 |
| 992 | 55/hr | 1 |
| 993 | 37/hr | 1 |
| 994 | kadir | 1 |
| 995 | mdct/mr | 1 |
| 996 | patients'or | 1 |
| 997 | ivbor | 1 |
| 998 | ziguinchor | 1 |
| 999 | bu+clo+flu+sor | 5 |
| 1000 | tpr/fpr | 1 |
| 1001 | 327±88u.carr | 1 |
| 1002 | 96hour | 1 |
| 1003 | clidox-s | 2 |
| 1004 | ≤15ml/s | 1 |
| 1005 | 6m/s | 1 |
| 1006 | late-1990s | 1 |
| 1007 | pro35s | 1 |
| 1008 | c6s | 1 |
| 1009 | bilharzias | 2 |
| 1010 | microatheromas | 2 |
| 1011 | angiomyxomas | 2 |
| 1012 | ∑20pcbs | 2 |
| 1013 | cs-tdcs | 4 |
| 1014 | carbapenemics | 1 |
| 1015 | pharmaco-economics | 4 |
| 1016 | teleosemantics | 1 |
| 1017 | antibiotics/chemotherapeutics | 2 |
| 1018 | bronchosecretolytics | 1 |
| 1019 | wlcs | 1 |
| 1020 | quadrupeds | 1 |
| 1021 | 132-h-olds | 1 |
| 1022 | 44-year-olds | 4 |
| 1023 | 54-year-olds | 3 |
| 1024 | 64-year-olds | 3 |
| 1025 | 17-year-olds | 17 |
| 1026 | 19-year-olds | 4 |
| 1027 | 59-year-olds | 2 |
| 1028 | 69-year-olds | 3 |
| 1029 | 18-yr-olds | 1 |
| 1030 | 10-yearolds | 1 |
| 1031 | flatus/feces | 1 |
| 1032 | postdifferences | 1 |
| 1033 | hepta-bdes | 1 |
| 1034 | non-suicides | 1 |
| 1035 | nonamputees | 1 |
| 1036 | therapeutic-modalities | 1 |
| 1037 | anareolineales | 1 |
| 1038 | pleurocapsales | 1 |
| 1039 | non-thermophiles | 1 |
| 1040 | thioles | 1 |
| 1041 | 2-aryl-2,5-dihydro-1h-pyrroles | 1 |
| 1042 | cervugid-ovules | 1 |
| 1043 | mainframes | 1 |
| 1044 | nursing-homes | 2 |
| 1045 | mvbs/lysosomes | 1 |
| 1046 | lysosomes/autolysosomes | 1 |
| 1047 | cuproenzymes | 1 |
| 1048 | rbc-membranes | 1 |
| 1049 | 3-pyridylnitrenes | 2 |
| 1050 | aminodinitrotoluenes | 1 |
| 1051 | pyrazolidines | 1 |
| 1052 | n-sulfonylaziridines | 1 |
| 1053 | landlines | 7 |
| 1054 | tetracylines | 1 |
| 1055 | methylxantines | 2 |
| 1056 | azt-backbones | 1 |
| 1057 | 1,4,16-pregnatriene-3,20-diones | 1 |
| 1058 | dihydroquinones | 1 |
| 1059 | hbv-genotypes | 2 |
| 1060 | test-temperatures | 3 |
| 1061 | lignocellulases | 1 |
| 1062 | endoxylanases | 3 |
| 1063 | mastreviruses | 1 |
| 1064 | bias.meta-analyses | 2 |
| 1065 | dates | 396 |
| 1066 | thiolates | 3 |
| 1067 | nestmates | 1 |
| 1068 | 2,3-dihydroazetes | 1 |
| 1069 | metamyelocytes | 1 |
| 1070 | microspherocytes | 1 |
| 1071 | conditioned-cues | 1 |
| 1072 | cys-orthologues | 1 |
| 1073 | cancerous-tissues | 1 |
| 1074 | cardiomyoctyes | 1 |
| 1075 | micron-sizes | 1 |
| 1076 | pre-ekgs | 1 |
| 1077 | internet/blogs | 1 |
| 1078 | exercise+hsgs | 2 |
| 1079 | multidrugs | 1 |
| 1080 | tfeis | 1 |
| 1081 | helmintiasis | 1 |
| 1082 | dyserythopoiesis | 1 |
| 1083 | sds-electrophoresis | 1 |
| 1084 | paraphymosis | 1 |
| 1085 | hypo-vitaminosis | 1 |
| 1086 | ovalocytosis | 1 |
| 1087 | eds-analysis | 1 |
| 1088 | sphincterolysis | 2 |
| 1089 | rectitis | 1 |
| 1090 | multi-peaks | 1 |
| 1091 | brickworks | 1 |
| 1092 | shoals | 3 |
| 1093 | follow-up/withdrawals | 1 |
| 1094 | alkoxypropanols | 1 |
| 1095 | pcos-controls | 1 |
| 1096 | 350ms | 1 |
| 1097 | 117.24+/-27.21ms | 1 |
| 1098 | 118.41+/-21.34ms | 1 |
| 1099 | 31±1.8ms | 1 |
| 1100 | 189.27+/-28.49ms | 1 |
| 1101 | vlcd-programs | 1 |
| 1102 | ss-lactams | 1 |
| 1103 | betalactams | 8 |
| 1104 | ttcms | 2 |
| 1105 | haems | 3 |
| 1106 | situations/problems | 1 |
| 1107 | passeriforms | 1 |
| 1108 | paired-tms | 1 |
| 1109 | calbicans | 1 |
| 1110 | l-halotryptophans | 1 |
| 1111 | asthmagens | 1 |
| 1112 | nonteratogens | 1 |
| 1113 | nε-hcy-proteins | 1 |
| 1114 | trophins | 2 |
| 1115 | amino-penicillins | 4 |
| 1116 | lynchpins | 1 |
| 1117 | 3,4-dihydrocoumarins | 1 |
| 1118 | endolysins | 1 |
| 1119 | grayanotoxins | 2 |
| 1120 | falsifications | 2 |
| 1121 | p495-mutations | 1 |
| 1122 | supra-infections | 1 |
| 1123 | haemos | 1 |
| 1124 | rips | 2 |
| 1125 | s-lps | 4 |
| 1126 | swelling/hydrops | 1 |
| 1127 | 13years | 2 |
| 1128 | 24years | 1 |
| 1129 | ⩽4years | 1 |
| 1130 | vernaculars | 1 |
| 1131 | super-shedders | 1 |
| 1132 | packers | 1 |
| 1133 | -adrenoblockers | 2 |
| 1134 | never-drinkers | 1 |
| 1135 | self-needlers | 1 |
| 1136 | fluorimeters | 1 |
| 1137 | non-crossovers | 1 |
| 1138 | er/pr+tumors | 1 |
| 1139 | semi-reflectors | 1 |
| 1140 | non-doctors | 2 |
| 1141 | exemptors | 1 |
| 1142 | eight-hours | 3 |
| 1143 | mfs/cess | 2 |
| 1144 | confess | 9 |
| 1145 | poeticness | 1 |
| 1146 | woman-centredness | 1 |
| 1147 | cuteness | 1 |
| 1148 | commonness | 2 |
| 1149 | tension/stress | 1 |
| 1150 | aa-subjects | 1 |
| 1151 | nonsubjects | 1 |
| 1152 | delivery.results | 1 |
| 1153 | heart-failure-patients | 1 |
| 1154 | treadmill-tests | 1 |
| 1155 | mists | 4 |
| 1156 | non-chemists | 1 |
| 1157 | aquarists | 1 |
| 1158 | systematists | 1 |
| 1159 | just/us | 2 |
| 1160 | administer.thus | 1 |
| 1161 | 1/radius | 1 |
| 1162 | pyrearinus | 1 |
| 1163 | microphlypnus | 1 |
| 1164 | isoviscous | 1 |
| 1165 | hiv-serostatus | 3 |
| 1166 | aerofluxus | 1 |
| 1167 | 60days | 7 |
| 1168 | 40°s | 1 |
| 1169 | 14t | 8 |
| 1170 | ifosfamide/heat | 1 |
| 1171 | 3-xorsat | 1 |
| 1172 | post-fbt | 1 |
| 1173 | self-react | 1 |
| 1174 | pre-ect | 1 |
| 1175 | self-reflect | 1 |
| 1176 | introspect | 2 |
| 1177 | self-protect | 5 |
| 1178 | bronchoconstrict | 1 |
| 1179 | staggered-onset | 1 |
| 1180 | shoplift | 3 |
| 1181 | high-expected-benefit | 1 |
| 1182 | glit | 2 |
| 1183 | 5=difficult | 1 |
| 1184 | culture-result | 1 |
| 1185 | 0.42/patient | 1 |
| 1186 | 0.74/patient | 1 |
| 1187 | misjudgment | 1 |
| 1188 | hcv/treatment | 1 |
| 1189 | non-employment | 2 |
| 1190 | hiv-1-rt | 1 |
| 1191 | 5-fu/rt | 1 |
| 1192 | soothe/comfort | 1 |
| 1193 | midtest | 6 |
| 1194 | hierarchist | 1 |
| 1195 | control/waiting-list | 1 |
| 1196 | no-tvt | 1 |
| 1197 | cav3-wt | 3 |
| 1198 | bu+clo+flu | 3 |
| 1199 | ziwu | 2 |
| 1200 | -0.76v | 1 |
| 1201 | ratrav | 3 |
| 1202 | lp1-ibdv | 2 |
| 1203 | rehberg-tareev | 1 |
| 1204 | 27mev | 1 |
| 1205 | ohv | 4 |
| 1206 | -67.7±1.8mv | 1 |
| 1207 | 2.1ppmv | 1 |
| 1208 | 65.4ppmv | 1 |
| 1209 | srascov | 1 |
| 1210 | 1691µv | 1 |
| 1211 | cpap.new | 1 |
| 1212 | 97kw | 1 |
| 1213 | wkw | 1 |
| 1214 | society-low | 1 |
| 1215 | pre-flow | 1 |
| 1216 | βalanlecycmshhex | 1 |
| 1217 | lhex | 2 |
| 1218 | vivonex | 1 |
| 1219 | patients'sex | 1 |
| 1220 | 40g/day | 3 |
| 1221 | 0.40-0.50mg/kg/day | 1 |
| 1222 | 80µg/day | 1 |
| 1223 | 3.5μg/day | 1 |
| 1224 | friday | 75 |
| 1225 | lack-of-efficacy | 1 |
| 1226 | iodine-deficiency | 1 |
| 1227 | non-persistency | 1 |
| 1228 | play/study | 1 |
| 1229 | co-classify | 1 |
| 1230 | 300kgy | 1 |
| 1231 | me/pathophysiology | 1 |
| 1232 | cineangiocoronarography | 1 |
| 1233 | cerebrovasculopathy | 1 |
| 1234 | myalgia-myopathy | 1 |
| 1235 | vitebsky | 1 |
| 1236 | €235.750/qaly | 1 |
| 1237 | 26,439euro/qaly | 1 |
| 1238 | real-timely | 1 |
| 1239 | t-family | 1 |
| 1240 | placebo.finally | 1 |
| 1241 | fluoxetine-only | 4 |
| 1242 | traditional-only | 4 |
| 1243 | smartsteps-only | 2 |
| 1244 | marcus.currently | 1 |
| 1245 | fimbriectomy | 2 |
| 1246 | adenotonsilectomy | 1 |
| 1247 | 5.1/100py | 1 |
| 1248 | corticoid-therapy | 1 |
| 1249 | vaginal-vault-brachytherapy | 1 |
| 1250 | ventriculoscopy | 1 |
| 1251 | weight-recovery | 1 |
| 1252 | extensiometry | 1 |
| 1253 | adiabaticity | 2 |
| 1254 | ne/erp-variability | 1 |
| 1255 | response/tolerability | 1 |
| 1256 | transdisciplinarity | 1 |
| 1257 | width-discontinuity | 1 |
| 1258 | 2.0z | 1 |
| 1259 | ih-c₆₀ | 1 |
| 1260 | 38.3℃ | 1 |
| 1261 | c₆₄ | 1 |
| 1262 | +1⅓ | 1 |
| 1263 | 5.7× | 1 |
| 1264 | 1.94±0.34† | 1 |
| 1265 | handihaler™ | 1 |
| 1266 | 16.10€ | 1 |
| 1267 | 46.80€ | 1 |
| 1268 | 38,921€ | 1 |
| 1269 | 7,253€ | 1 |
| 1270 | -11‰ | 1 |
| 1271 | +180° | 1 |
| 1272 | 44.7°±12.3° | 1 |
| 1273 | 154° | 1 |
| 1274 | ±4° | 1 |
| 1275 | 175° | 1 |
| 1276 | ≤5° | 3 |
| 1277 | 247° | 1 |
| 1278 | β-silyl-α | 1 |
| 1279 | d14-3-3ε | 1 |
| 1280 | 12º | 1 |
| 1281 | 95.5º | 1 |